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Abstract 
 Cells respond to extracellular stimuli by modulating intricately intertwined 
signaling pathways. To achieve specific responses, these pathways are tightly controlled 
in space and time by regulating second messenger concentrations and kinase activity 
dynamics. The 3'-5'-cyclic adenosine monophosphate (cAMP)/cAMP-dependent protein 
kinase (PKA) pathway is spatiotemporally compartmentalized at various levels in order 
to elicit specific cellular activities. At the second messenger level, cAMP concentration 
gradients are maintained by actively controlling its accumulation and degradation. PKA 
activity is also modulated in space and time by the spatiotemporal compartmentalization 
of upstream components, including cAMP gradients, and is itself spatially localized to 
specific subcellular compartments, contributing to highly specific substrate recognition. 
Moreover, interactions with signaling molecules from other signaling pathways serve as 
another source of regulation of the cAMP/PKA pathway. To study cAMP and PKA in 
their native environment, wherein the entire signaling network remains intact, we used 
fluorescence resonance energy transfer (FRET)-based biosensors to capture their 
endogenous signaling dynamics. 
 This dissertation is composed of two parts. The first part consists of two studies, 
which investigate the role of spatiotemporally compartmentalized PKA signaling in two 
separately important biological processes. In the first study, we used FRET-based PKA 
reporter (AKAR4-Kras) to study how cells tune PKA activity to transition between 
different modes of migration in response to different degree of physical confinement. We 
demonstrate the importance of crosstalk between different signaling pathways in 
regulating PKA activity to enable cells to adapt to their microenvironment and migrate 
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efficiently. In the second study we also employed FRET-based reporters to profile 
compartment-specific Akt activity dynamics in PC12 cells. We observed spatial 
differences of Akt as well as interesting temporal dynamics in response to EGF and NGF. 
While dissecting the molecular mechanisms governing compartment-specific Akt 
activity, we demonstrated a complex interaction between PKA and Akt that could 
regulate the differentiation of PC12 cells.  
The second portion of the dissertation involves developing enhanced BRET- and 
FRET-based reporters to sensitively monitor kinase activity (Bim-BRET-KARs) and 
cAMP levels (ICUE4), respectively. We demonstrated the ability of Bim-BRET-KARs in 
detecting various kinase activities with high spatial resolution, and the applicability of 
these reporters to be used in combination with fluorescent molecules and optogenetic 
tools. We also generated a cAMP reporter that can detect low cAMP levels that were 
previously undetectable by current FRET-based cAMP reporters.  
 Taken together, the studies presented herein highlight various modes and roles of 
spatiotemporally compartmentalized cAMP/PKA signaling in modulating specific 
cellular processes. Moreover, utilizing the newly developed tools, we have elucidated 
dynamics of the cAMP/PKA signaling that we previously could not visualize. These 
studies enhance our understanding of the cAMP/PKA pathway and unveil unknown roles 
it plays in biological processes. 
 
 
Thesis Advisor: Dr. Jin Zhang 
Second Thesis Reader: Joy Yang 
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Intracellular signaling and phosphorylation 
 Our bodies must intrinsically adjust to small and large changes to help us adapt to 
and survive in new environments. In response to these changes, organs and tissues release 
signaling molecules such as neurotransmitters, hormones, and polypeptides. Once 
released, these signaling molecules bind to specific receptors on the cell membrane, 
initiating a series of intracellular biochemical events that includes the production of 
second messengers and the modification of the concentrations and activities of 
downstream target proteins, which function to amplify the initial signals and mediate 
cellular effects. This series of events, known as intracellular signal transduction, 
influences a variety of cellular processes, such as cell migration and neuronal 
differentiation, which are ultimately manifested as physiological responses to 
environmental changes.  
One of the most common ways in which cells modulate protein behavior is 
through the transfer of a phosphate group from ATP to specific serine, threonine, or 
tyrosine residues within proteins, a process known as phosphorylation.  The first inkling 
of phosphorylation came during the early 20th century from studies by Phoebus Levene 
and Carl Alsberg, who observed portions of vitellin, a protein found in egg yolk, that 
were attached to phosphoric acid via an ester linkage1. Similarly, in 1954, Burnett and 
Kennedy hinted that a liver enzyme could be responsible for adding a phosphate group to 
casein, yet it remained unclear how or why either of these processes occurred2.  
Meanwhile, in the 1930s, through their research into carbohydrate metabolism, 
Carl and Gerty Kori characterized glycogen phosphorylase, which initiates the 
breakdown of glycogen, noting that this enzyme existed in two distinct forms: 
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phosphorylase a (active) and phosphorylase b (inactive)3, 4. In collaboration with Krebs 
and Fischer, the Koris also discovered the reversibility of phosphorylation through 
enzymes known as protein phosphatases5. From this work, they were able to correlate the 
two forms of phosphorylase to the phosphorylated/dephosphorylated state of the protein. 
Krebs and Fischer further demonstrated that the phosphorylation of glycogen 
phosphorylase required the presence of Mg-ATP and an enzyme first identified as 
phosphorylase kinase. Specifically, phosphorylase kinase activated phosphorylase b by 
hydrolyzing and transferring the γ-phosphate group of ATP to a specific serine residue on 
phosphorylase b, converting it to phosphorylase a.  
At the same time, Rall and Sutherland showed that phosphorylase levels increased 
in the liver in response to glucagon and adrenaline. Thanks to the above insights into 
phosphorylase a activation, it became clear that ATP and phosphorylase kinase were the 
link between hormones and phosphorylase a. Further studies subsequently showed that 
hormones such as adrenaline can modulate intracellular processes by inducing the 
production of cyclic 3’,5’ adenosine monophosphate (cAMP)6. Finally in 1968, Krebs 
and his group identified the enzyme responsible for phosphorylating casein and 
phosphorylase kinase as a cAMP-dependent protein kinase, or protein kinase A (PKA), in 
the skeletal muscle of rabbits7.  
Since the discovery of phosphorylation and PKA, phosphorylation has been 
shown to play a central role in human physiology and disease. The human genome is now 
known to encode approximately 518 protein kinases and a third that number of protein 
phosphatases.  Moreover, roughly 200,000 phosphorylation sites have been reported in 
the human proteome8, 9. Phosphorylation has multiple roles that include inducing 
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conformational changes, or the creation of surfaces with distinct binding properties that 
influence protein activity, localization and the recruitment of other signaling molecules. 
The dysregulation of kinases leads to abnormal phosphorylation that has been uncovered 
and implicated in many human diseases, including cancer, diabetes, hypertension, and 
neurodegenerative disorders10. For example, in the 1990s, Jack Dixon discovered that a 
major virulence factor of Yersinia pestis is a protein tyrosine phosphatase11. This class of 
bacteria causes several serious diseases, including the bubonic plague, which has been 
responsible for many pandemics over the past millennium; as early as the 12th and 13th 
centuries, one of the most famous outbreaks of the bubonic plague, the Black Death, was 
responsible for killing 25% of the population of Europe (42 million people). In addition, a 
number of naturally occurring toxins and tumor promoters exert their effects by targeting 
particular protein kinases and phosphatases to alter phosphorylation levels of important 
proteins12. As a result, many protein kinase inhibitors, such as fasudil, rapamycin, 
Gleevec, and Lapatanib, which target Rho dependent kinase, TOR, and BCR-Abl, and 
EGFR, respectively, are currently in clinical use to treat various diseases13. Given the 
importance of PKA and other kinases as signaling molecules and given that targeting 
kinase-mediated signaling has vast therapeutic potential, it is important to understand the 
molecular mechanisms underlying proper protein phosphorylation14, 15.  
   
cAMP/PKA signaling pathway 
Cells communicate with their extra- and intracellular environments using signal 
transduction pathways that relay messages into functional responses. As mentioned 
earlier, Rall and Sutherland first linked hormones, an extracellular signal, to changes in 
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phosphorylation, which ultimately modifies protein function. Soon afterwards, 
Sutherland identified the first second messenger, cyclic 3’,5’ adenosine monophosphate 
(cAMP), which serves to amplify the extracellular signal and efficiently modulate the 
function of its downstream targets, known as effector proteins. By regulating its effector 
proteins, cAMP can regulate numerous cellular functions, including insulin secretion, cell 
growth and differentiation, muscle contraction, and long-term memory formation. The 
classical route of cAMP production is initiated when an extracellular stimulus such as a 
hormone or neurotransmitter binds to a G-protein-coupled receptor (GPCR) on the cell 
surface and activates the associated heterotrimeric G protein. The inactive trimer consists 
of a GDP-bound, stimulatory Gα subunit tightly bound to a Gβγ heterodimer. Stimulated 
GPCRs function as guanine-nucleotide exchange factors (GEFs), causing Gα to release 
GDP and bind free GTP. GTP-binding causes Gα to undergo a conformational change, 
leading to its dissociation from Gβγ.  Depending on the type of α subunits (Gαs, Gαi, 
Gαq/11, Gα12/13), G-proteins can further affect intracellular signaling proteins 16. 
Specifically, once Gαs dissociates from Gβγ, it associates with and activates 
transmembrane adenylyl cyclase (tmAC), which catalyzes the conversion of intracellular 
ATP into cAMP19, 20 (Fig. 1.1). Once produced, cAMP can activate effector proteins such 
as PKA and Epac. 
PKA was the first discovered cAMP effector and is one of the best characterized 
protein kinases. The inactive PKA holoenzyme exists as a heterotetrameric enzyme that 
consists of two regulatory (R) and two catalytic (C) subunits. There are four known 
isoforms of the R subunit (RIα, RIβ, RIIα, and RIIβ), along with three C subunit isoforms 
(Cα, β, γ) that are largely identical to each other but exhibit slight differences in tissue- 
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Figure 1.1 The cAMP Signaling Pathway  
Following input of an appropriate signal, tmAC and/or sAC is activated to produce 
cAMP from intracellular ATP. Once produced, cAMP activates its downstream effectors, 
PKA or Epac. Degredation of cAMP is achieved by phosphodiesterases, which can help 
to form gradients of cAMP within the cell. 
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specific expression17. The cooperative binding of cAMP to the two R subunits induces a 
conformational change that leads to the release of active catalytic subunits18. The 
catalytic subunits are responsible for phosphorylating PKA substrates and contain two 
binding sites, one for the peptide substrate and the other for binding of ATP. Unlike the 
catalytic subunits, the R subunits (RI, RII) exhibit distinct molecular weights, protein 
sequences, phosphorylation states, cAMP-binding affinities, tissue distributions, and 
subcellular localizations. The RII subunits can be phosphorylated by the catalytic 
subunits, whereas RI subunits cannot19. Furthermore, the type I PKA holoenzyme (RIα 
and RIβ) is predominantly cytoplasmic, whereas the majority of type II PKA (RIIα and 
RIIβ) associates with cellular structures such as the plasma membrane, cytoskeleton, 
nuclear membrane, secretory vesicles, and organelles. In addition, the RIα and RIIα 
subunits are expressed in most tissues while RIβ and RIIβ are selectively expressed in the 
central nervous system and in reproductive tissues20. The distinct, isoform-specific 
expression patterns of the R subunits allow PKA to effectively phosphorylate specific 
substrates that are required for many tissue-specific cellular processes, including 
metabolism, gene expression and muscle contraction.  
A more recently discovered cAMP effector, Epac functions as a GEF for Rap1 
and Rap2, members of the Ras G-protein family. Upon cAMP binding, Epac is recruited 
to the plasma membrane and activates Rap by exchanging bound GDP for GTP21, 22. Epac 
has two main domains, a regulatory domain and a catalytic domain, each of which 
consists of a series of smaller functional units. The regulatory region contains the cAMP-
binding domain (cNBD) and a Dishevelled, Egl-10, Pleckstrin (DEP) domain, which is 
involved in membrane localization. The catalytic domain consists of a Ras-exchange 
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motif (REM), a Ras-association (RA) domain and CDC25-homology domain (CDC25-
HD). There are two Epac isoforms, Epac1 and Epac2: Epac1 has only one cNBD and is 
expressed in all tissues. Epac2, on the other hand, is expressed mainly in adrenal, 
pancreatic and neuronal tissues and has two cNBDs. cNBD1, located at the N-terminus of 
Epac2, exhibits a lower cAMP binding affinity (Kd=87µM) than cNBD2 (Kd =1.2 µM)23. 
Despite these differences, the DEP, REM, RA, and CDC25-HD domains are conversed 
between both Epac isoforms. Prior to cAMP binding, Epac exists in a closed 
conformation wherein the protein folds onto itself such that the regulatory and catalytic 
domains interact with one another. This conformation is held together by an ionic 
interaction (“ionic latch”) between the CDC25-HD and the N-terminal helical bundle of 
the cNBD, along with a “hinge-region” located between the cNBD and the REM domain. 
This closed conformation prevents members of the Ras family of GTPases, such as Rap, 
from interacting with the catalytic domain. Upon cAMP binding to the cNBD, the ionic 
interaction is disrupted and the cNBD rotates away via the “hinge region” of the 
regulatory domain, creating an open conformation that exposes the CDC25-HD to GDP-
bound Rap124-26. 
Compared with PKA, Epac binds cAMP with much lower affinity. Furthermore, 
although Epac and PKA can act independently, given their common upstream regulation, 
there is often overlap between these two signaling pathways. Many cAMP-mediated 
effects that were previously thought to act through PKA alone may also be transduced by 
Epac. Extensive studies have established that Epac proteins are involved in a host of 
cAMP-related cellular functions such as cell adhesion, cell-cell junction, 
exocytosis/secretion, cell differentiation and proliferation, gene expression, apoptosis, 
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cardiac hypertrophy and phagocytosis27-29.Therefore, there is a need to develop small 
molecules that can act as Epac- or PKA-specific inhibitors and activators30-32. In addition, 
due to the tissue and cell-type specificity of Epac, the role of Epac2 in diabetes-related 
diseases, hypertrophy, and Alzheimer’s has generated considerable interest33-35.  
 
Spatiotemporal Compartmentalization of the cAMP/PKA Signaling Pathway 
The cAMP signaling pathway controls a wide range of cellular processes in 
response to specific stimuli. However, as cAMP signaling became associated with more 
and more cellular functions, scientists found themselves at a loss to explain how PKA 
“knew” which targets to phosphorylate in response to which stimuli. In cardiac muscles, 
for example, it was thought that increases in cAMP would lead to overall activation of 
PKA, and the subsequent phosphorylation of phosphoryase kinase and glycogen synthase 
to stimulate glycogenolysis to facilitate cardiac contraction. However, it was shown that 
upon prostaglandin (PGE1) stimulation in rat hearts, these PKA substrates were inactive 
even though cAMP concentration increased36. Meanwhile isoproterenol, which causes 
similar effects as PGE1 in rat and guinea pig hearts, did lead to the activation of glycogen 
phosphorylase. Additional studies also revealed that cAMP, PKA, and PKA substrates 
were bound in varying amounts to particular sites within cardiac tissues37. Similarly, later 
studies also demonstrated that specific adenylyl cyclases, were activated by specific 
receptors. Altogether, these studies demonstrated how specific external stimuli could 
increase cAMP in specific intracellular spaces. Thus, despite some initial skepticism, the 
idea that cAMP signaling is dependent on subcellular compartmentalization emerged. 
Since these pioneering studies, various factors have been found to directly contribute to 
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the compartmentalization of cAMP/PKA signaling at level of the receptor, at the level of 
cAMP production and degradation, and at the effector level. 
 
Receptors and Adenylyl cyclases 
One critical factor in the spatiotemporal regulation of cAMP-mediated signaling 
is the dynamic cellular organization of adenylyl cyclase (AC) localization. Of the ten 
different AC isoforms in mammals, nine are classified as transmembrane ACs (tmACs). 
tmAC are localized throughout the plasma membrane, in close proximity to 
heterotrimeric G proteins that can regulate tmAC activity upon hormone and 
neurotransmitter binding to GPCRs. Within the plasma membrane, tmACs can be 
localized in various membrane subdomains to regulate their activity. For instance, tmACs 
tend to exist throughout the cell membrane, while in certain cell types the β2-adrenergic 
receptor (β2-AR), a Gαs-coupled GPCR, is known to localize specifically to cholesterol-
rich membrane rafts. This spatial restriction in the access of Gαs and tmAC to β2-AR is a 
mechanism to properly regulate the level of cAMP production from β2-AR. In addition, 
tmACs associate with different types of proteins that differentially regulate tmAC 
activity. For example, whereas the Gα isoform Gαs is a stimulator of cAMP production,, 
another class of G-proteins that consists of Gαi acts as an inhibitor of cAMP production. 
Acetylcholine is an example of a neurotransmitter that mediates cell signaling through 
binding to M2 receptors and activation of Gαi38. tmACs can also be expressed in different 
tissues to mediate different cellular processes and signaling events, depending on the 
localization and type of receptors. For example, AC1 is expressed in neurons and 
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therefore is involved in memory formation, while AC5 resides in the heart and 
contributes to cardiac function39.  
In contrast to the nine tmACs, the recently discovered AC10 is classified as a 
soluble AC (sAC) that is distributed throughout the cell, including in discrete 
compartments such as the nucleus, mitochondria, centrioles or cilia 40, 41. The discrete 
localization of sAC to subcellular compartments allows it to regulate specific 
downstream targets of cAMP. Unlike tmACs, sACs are specifically activated by 
bicarbonate and Ca2+, with the former allowing sAC to function as a general 
bicarbonate/CO2 or pH sensor for metabolic reactions42. It has been found that sAC are 
highly expressed in sperm cells, consistent with the role of AC activity in sperm 
maturation, motility, capacitation, and in the acrosome reaction. Moreover, the 
bicarbonate concentration at which recombinant sAC is activated is well within the 
concentration range found in epididymal fluid43.  
 
Phosphodiesterases 
 While cAMP/PKA signaling can be regulated as early as the production of cAMP, 
it can also be regulated through the degradation of cAMP by phosphodiesterases (PDEs). 
PDEs are a group of enzymes that degrade cAMP to AMP by hydrolyzing the 
phosphodiester bond between the phosphate group and AMP. Given that cAMP can 
rapidly diffuse throughout the cell following its production by ACs, PDEs play a critical 
role in restricting the aberrant dispersion of cAMP and generating localized pools or 
gradients within the cell to target specific groups of effector molecules. The first hint of 
PDE-regulated cAMP microdomains came from studies in cardio myocytes by Hohl and 
Li in the early 1990s44. They found that the cytosolic and particulate pools of cAMP 
	   12	  
responded differently to same cAMP-elevating reagents. Based on the presence of 
various types of PDEs expressed in cardiac tissue, they and other groups speculated that 
PDEs were responsible for generating this non-uniform intracellular distribution of 
cAMP. Since then, accumulating evidence has shown that PDEs are vital to 
compartmentalized cAMP/PKA signaling by controlling the localization, duration, and 
amplitude of cyclic nucleotide signaling within subcellular domains.  
cAMP/PKA signaling is differentially regulated by various PDE isoforms. There 
are eleven families of PDEs which contain multiple isozymes with subcellular, cell type-, 
and tissue-specific distributions and effects. While the carboxy-terminal catalytic domain 
of each PDE is highly conserved, the amino-terminal regions of these proteins are highly 
diverse, being responsible for the unique regulation and targeting of individual PDEs to 
strategic subcellular sites45. The specific localization of PDEs confers their particular 
functions in regulating specific cAMP pools. For example, PDE3 has been shown to be 
important in the spatial compartmentalization of growth factor-stimulated PKA activity to 
the plasma membrane of PC12 cells46. In addition, PDE1C2 isoforms, which are highly 
localized in olfactory epithelium of the brain, are thought to play an important role in the 
rapid regulation of cAMP responses to odorants47.  
PDEs themselves can also be regulated by diverse biochemical mechanisms 
including phosphorylation/dephosphorylation. For instance, PDE3 can also be regulated 
via phosphorylation by PKA in response to hormonal stimulation in several cell types48. 
Phosphorylation enhances PDE3 activity and constitutes a negative feedback loop to 
ensure that cAMP levels are properly maintained.  
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 While ACs release cAMP in a particular region in response to change in the 
extracellular environment, sequestered PDEs help sculpt localized cAMP gradients, by 
setting the ‘gate’ for activation of associated effector systems, as well as by protecting 
them from inappropriate activation by fluctuations in basal cAMP levels. The coordinated 
action of PDEs and ACs help finely tune the level and persistence of the cAMP/PKA 
signaling at that particular spatial locale to efficiently adjust specific physiological 
processes.   
 
A-Kinase Anchoring Proteins (AKAPs)  
Another critical component in the formation of localized cAMP-mediated 
signaling networks are A-kinase anchoring proteins (AKAPs), which act as scaffolding 
proteins to specifically tether PKA to dedicated PKA substrates such as GPCRs, tyrosine 
kinase receptors, and ion channels. In a sense, AKAPs help facilitate rapid, efficient, and 
enhanced signal transmission in local environments through substrate phosphorylation. 
Currently, more than 70 diverse AKAPs are known to be expressed in a cell- and 
organelle-specific fashion49.  
AKAPs interact with PKA through direct binding between amphipathic 14–18 
amino-acid long α-helical region of the AKAP and the N-terminal docking/ dimerization 
(D/D) domain formed by the first forty-five amino acids of the R subunit50. The majority 
of AKAPs specifically interact with RII subunits; however, a handful of AKAPs that 
interact with the RI subunit have also been discovered. Some of these RI-interacting 
AKAPs are dual-specificity AKAPs such as ezrin, D-AKAP1, D-AKAP2, merlin, and 
AKAP22051. Generally in dual-specificity AKAPs, the affinity for RI subunits is lower 
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than that for RII subunits51. To date, known RI-specific AKAPs include, sphingosine 
kinase interacting protein (SKIP), which is found in heart tissue, and the RI-specific 
interaction is believed to be mediated by aromatic residues in the SKIP helix that are 
missing from both RII- and dual-specificity AKAPs, and integrins52-54.  
With unique targeting domains, AKAPs are able to sequester PKA to subcellular 
regions where PKA substrates are in close proximity for efficient modulation by PKA,. 
AKAPs are able to sequester PKA to subcellular regions where PKA substrates are in 
close proximity for efficient modulation by PKA, due to unique targeting domains within 
AKAPs. For example, members of the S-AKAP84/D-AKAP1 family contain a consensus 
sequence for targeting to the outer mitochondrial membrane. Similarly, AKAP15/18 is 
targeted to the plasma membrane through lipid modifications, namely, myristoylation and 
palmitoylation. mAKAP, a muscle-selective anchoring protein, was also shown to be 
targeted to the perinuclear location through a sequence region that contains spectrin-like 
repeats.  
In addition to PKA, AKAPs can bind to key cAMP-regulating enzymes, namely, 
ACs and PDEs, to dictate the level and persistence of the cAMP signal and to 
subsequently regulate PKA activity at that particular spatial locale. Moreover, some 
AKAPs can bind additional signaling molecules such as protein kinases, phosphatases, 
GTPases and adaptor proteins so as to provide additional regulatory components and 
integrate different signaling pathways into these compartmentalized complexes. 
Disruption of these AKAP-mediated interactions can lead to aberrant PKA activity and 
therefore diseases such as cardiac hypertrophy and heart failure55. Hence, AKAPs help 
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add another layer of complexity by forming a network that synchronizes multi-protein 
signaling that is required for tightly regulating specific cellular processes.  
 
Crosstalk between cAMP/PKA and other signaling pathways  
As an added level of complexity in signal transduction regulation, many canonical 
signal transduction cascades are subject to crosstalk, wherein the signaling status of one 
pathway alters the state of another. For instance, as mentioned above, AKAPs facilitate 
crosstalk between the cAMP/PKA pathway and other signaling pathways through their 
interactions with various types of signaling molecules. This allows cells to tailor the 
cAMP signaling network to control specific cellular process. In particular, the 
cAMP/PKA pathway engages in extensive crosstalk with the calcium signaling pathway, 
as well as with other kinase signaling pathways, including the MAPK/ERK and PI3K/Akt 
signaling pathways.  
 
Calcium Signaling  
Calcium (Ca2+) is another ubiquitous second messenger that is associated with 
multiple cellular processes, including neurotransmission, muscle contraction, gene 
expression, cell proliferation, and cell death. The versatility of calcium signaling in 
various specific biological processes is attributed to its ability to interact with a wide 
variety of molecules that modulate its concentration to create different spatial and 
temporal profiles.  
The Ca2+ and cAMP pathways are very tightly regulated by mutual crosstalk, with 
each messenger able to regulate the levels of the other. For example, Ca2+ signals can 
modulate both the production and degradation of cAMP by regulating AC and PDE 
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activity in signaling hubs and microdomains. In general, AC1, AC3 and AC8 are each 
activated, whereas AC5 and AC6 are both inhibited, by physiological increases in Ca2+ 
concentrations. Ca2+ can also regulate ACs indirectly through PKC and Ca2+/calmodulin 
protein kinase CaMKII, such as AC2, 4, and 7 56. ACs are also known to be recruited to 
microdomains in close proximity to Ca2+ channels such as ryanodine receptors (RyR), L-
type Ca2+ channels and SERCA pumps through interactions with AKAPs. Similarly, 
PDE1 family members are positively regulated by the binding of Ca2+/calmodulin to two 
N-terminal calmodulin-binding domains, which activates PDE1 by relieving 
autoinhibition. Conversely, PKA can modulate the release of Ca2+ from intracellular 
stores by phosphorylating and activating calcium transporters such as the IP3R and RyR 
located on the ER surface. Furthermore, AKAP15 has been shown to be responsible for 
recruiting PKA to voltage-gated calcium channels (VGCCs) to regulate their activity. 
This crosstalk between Ca2+ and PKA provides a mechanism for achieving efficient and 
specific control of cellular processes such as exocytotic insulin release and cell 
migration57, 58.  
 
Crosstalk with other kinase signaling pathways  
In general, PKA can crossregulate with a slew of kinases. One of the most well-
studied signaling pathway interactions is between the PKA and MAPK/ERK pathways. 
MAPK cascades are typically initiated by the binding of growth factors to a receptor 
tyrosine kinase (RTK) on the cell surface.  This binding event induces 
autophosphorylation of the RTK and promotes the recruitment and binding of adaptor 
proteins to the RTK. This ultimately activates a small GTPase which subsequently 
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activates the first of three kinases in the MAPK cascade. In the case of ERK signaling, 
the GTPase Ras or Rap1 activates the first kinase in the cascade, Raf, which 
phosphorylates and activates MEK1/2, which then phosphorylates and activates ERK1/2. 
Studies have shown that PKA can differentially regulate ERK through the Raf isoforms 
B-Raf or Raf1, which are activated and inhibited, respectively, by PKA. Therefore, 
depending on the expression levels of these Raf isoforms, PKA can either inhibit or 
activate ERK activity. Furthermore, while both Raf isoforms are activated by Ras, only 
B-Raf is activated by Rap1; thus, the effect of PKA on ERK activity is also dependent on 
the expression levels of Ras and Rap1. 
The PKA and MAPK/ERK crosstalk has been shown to play a critical role in 
regulating cell fates. Traditionally in PC12 cells, a cell line derived from a 
pheochromocytoma of the rat adrenal medulla, ERK activity alone was thought to control 
the decision between differentiation and proliferation in these cells. Specifically, transient 
ERK activity induced by epidermal growth factor (EGF) binding to its cell surface 
receptor, the epidermal growth factor receptor (EGFR), induces proliferation, whereas 
sustained ERK activity induced by the binding of nerve growth factor (NGF) to TrkA 
causes cell differentiation59.  As further evidence of the crosstalk between cAMP/PKA 
and ERK signaling, however, PKA and PDE3 were shown to regulate both the onset and 
duration of GF-stimulated ERK activity. When PDE3 was inhibited and the 
spatiotemporal regulation of PKA disrupted, PC12 cells treated with EGF displayed 
prolonged nuclear ERK activity. A separate study using HEK293 cells, also found that 
KSR-1, a scaffold for proteins involved in the MAPK signaling pathway, and AKAP-Lbc 
form the core of a larger ERK network that incorporates PKA and integrates signals from 
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cAMP 60. With the recruitment of PKA to the MAPK signaling complex, PKA can 
phosphorylate KSR-1 to promote sustained ERK activity. AKAP-Lbc is responsible for 
recruiting PKA to this signaling complex by directly binding to three different Raf 
isoforms involved in the MAPK pathway61. As proper regulation of MAPK activity is 
involved in coordinating numerous cellular functions, including the regulation of cell 
growth and proliferation, the stress response, and apoptosis, an enhanced understanding 
of the spatiotemporal regulation of this pathway, including the cross-regulation by 
cAMP-mediated signaling, is necessary. 
Similarly, recent studies have also implicated PKA-Akt crosstalk in regulating 
cell differentiation in other cell types such as ovarian granulosa cells62. Moreover, this 
PKA-Akt crosstalk was shown to be mediated by an AKAP, GAB2. However, there are 
far fewer examples of PKA-Akt crosstalk in the literature, and the mechanism and 
function behind this interaction remains unclear. The studies presented in Chapter 3 
provide new insights into the regulation of Akt activity by cAMP/PKA signaling and vice 
versa. 
 
Methods for studying signal transduction pathways 
 As eluded to above, signal transduction pathways are subject to spatial and 
temporal modulation through a variety of complex molecular mechanisms. Disrupting the 
spatiotemporal regulation of signal transduction affects numerous processes, such as 
differentiation and migration that are vital to the survival of cells and organisms. 
Dissecting the mechanisms that govern signal specificity and developing a 
comprehensive understanding of the functional roles of these regulatory molecules in 
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various dynamic processes depends on the ability to study signal transduction in the 
native context of living cells, tissues, or organisms, wherein these processes are 
maintained intact. Furthermore, with an increasing numbers of studies highlighting the 
heterogeneity of cells within a tissue, there is a growing emphasis on studying single-cell 
behaviors63, 64. However, traditional methods to study signal transduction in cells rely 
heavily on biochemical techniques, including immuno-based assays, which often involve 
cell fixation or lysis and are utilize cell populations, thus leading to the loss of critical 
spatial and temoral information. For instance, these population-based assays often fail to 
capture biologically relevant dynamics such as oscillatory signaling and bistability65, 66, 
instead providing only static snapshots of signal transduction cascades. To alleviate many 
of these constraints, a number of tools have been developed to directly visualize and 
quantify specific signaling events with high spatial and temporal resolution within the 
native cellular context.  
 
Visualization of signal transduction pathways 
 Genetically encoded reporters have existed for close to two decades and allow the 
tracking of signal transduction events in real time with high spatiotemporal resolution. 
Being genetically encodable, these fluorescent reporters can be non-destructively 
introduced into living systems in the form of plasmid DNA, taking advantage of the 
intracellular machinery to synthesize the functional biosensor. Fluorescent biosensors 
have been utilized to monitor pH, Ca2+ levels, membrane potential, post-translational 
modifications, second messenger accumulation/degradation, and enzyme activity67-71. 
Moreover, these biosensors can be targeted to specific cells or subcellular locations to 
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monitor local signaling dynamics72-74. The ongoing development of biosensors capable of 
detecting new target molecules will continue to lead to discoveries in cell signaling.  
Likewise, the development of novel sensors with enhanced sensitivity will enable the 
study of signal transduction in new settings75. 
The most diverse and versatile class of genetically encoded fluorescent biosensors 
are based on fluorescence resonance energy transfer (FRET), which involves the 
nonradiative transfer of energy from an excited donor fluorophore to an acceptor 
fluorophore. Efficient energy transfer requires the two fluorophones to be close together 
(e.g., less than 10 nm apart) and to exhibit sufficient overlap between the donor emission 
spectrum and the acceptor excitation spectrum. FRET-based reporters are engineered to 
undergo a conformational change in response to a given biochemical event, such as 
phosphorylation, second messenger binding, or protein-protein interaction, which alters 
the distance and orientation between the two fluorophores. The module that undergoes 
conformational changes is known as the molecular switch. Therefore the readout for 
change in a signaling event is the change in FRET. Most commonly in FRET-based 
reporters, the two FPs are cyan fluorescent protein (CFP), which acts as the donor, and 
yellow fluorescent protein (YFP), which acts as the acceptor. 
 
Kinase activity reporters 
 Kinase-activity reporters (KARs) are a class of FRET-based biosensors that report 
on the dynamics of phosphorylation mediated by kinases. The general design of FRET-
based KARs consists of four components: the FRET donor (e.g., CFP), a kinase-specific 
substrate domain, a phosphoamino acid binding domain (PAABD), and a FRET acceptor 
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(e.g., YFP). Phosphorylation of the substrate domain induces the binding of the PAABD 
to the phosphopeptide, thus causing a conformational change that alters the distance 
and/or orientation between the FPs to produce a change in FRET. Following attenuation 
of signaling, for example, by internalization of the receptor or removal of the stimulus, 
phosphatases dephosphorylate the substrate domain, reversing the FRET change76. This 
general design has been applied to develop biosensors for a variety of kinases, including 
PKA, PKC, Akt/PKB, MAPKs, AMP-activated protein kinase (AMPK), and Proto-
oncogene tyrosine-protein kinase (Src). Furthermore, the modular design of KARs has 
enabled the creation of many new reporters through the substitution of one kinase-
specific substrate and/or PAABD for another (Fig. 1.2A). 
 An alternative strategy to designing kinase activity reporters is utilizing a 
naturally existing conformationally responsive element as the molecular switch. For 
example, TORCAR, a FRET-based mTORC1 activity biosensor, utilizes full-length 
4EBP1 (elF4E binding protein 1) as the molecular switch. Upon phosphorylation of 
4EBP1, a conformational change is induced leading to a change in FRET. In this case, 
this design strategy worked better than the molecular switch that consists of a short 
peptides substrate and PAABD77. Therefore, for TORCAR, the mTOR1 activity is 
detected as a decrease in FRET response. Depending on the type of conformational 
change that takes place, the FRET response can either increase or decrease upon kinase 
activation.  
Second messenger biosensors 
 Second messengers can take the form of small molecules, lipids, or ions, that 
relay signals received at receptors on the cell surface and amplify a physiological signal  
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Figure 1.2: Genetically encoded FRET-based biosensors  
(A) General design of a KAR that increases in FRET in response to endogenous kinase 
activation. (B) General design of a FRET-based second messenger biosensor that 









	   23	  
by regulating kinase activity. Well-studied second messengers include cyclic nucleotide 
monophosphates (cAMP and cGMP), diacylglycerol (DAG), phophstidylinositol 2,4,5-
triphosphate (PIP3), and Ca2+. Changes in second messenger concentrations are tightly 
regulated both spatially and temporally under physiological conditions, and this 
regulation is coupled to spatiotemporal control of its effector proteins. Currently, there 
are many FRET-based biosensors for detecting second messenger dynamics, including 
cAMP, Ca2+, cGMP, DAG, phosphoinositides, and nitric oxide78-81. As with KARs, 
second messenger biosensors contain molecular switches that often are the second 
messenger effector proteins because they undergo conformational change upon second 
messenger binding.  For example, the FRET-based cAMP biosensor, indicator 
of cAMP using Epac (ICUE), consists of Epac1 as the sensing domain, sandwiched 
between two fluorescent proteins, CFP and YFP. Prior to cAMP, Epac1 exists in a closed 
conformation, causing the FP to be in close proximity with one another. In presence of 
cAMP, Epac1 undergoes a conformational change that pulls the two FP apart. Therefore, 
upon increase in cAMP, the readout is a decrease in FRET (Fig. 1.2B). 
 
Development and improvement of genetically encoded biosensors  
The design and use of genetically encoded FRET-based biosensors has rapidly 
expanded our molecular understanding of numerous signaling pathways in a variety of 
biological systems. KARs are invaluable tools for studying kinase activity dynamics, but 
their utility may be restricted by a limited dynamic range, which can hinder the detection 
of minute yet physiologically relevant changes in kinase activity or for use in high-
throughput compound screens. Most traditional KARs are based on a unimolecular 
design. However, the relatively small separation of the FPs in the basal state may restrict 
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the maximum possible FRET change that can be achieved. Therefore, efforts to further 
improve the responses of kinase biosensors led to the generation of bimolecular KARs 
(bimKARs) that utilize a kinase-inducible bimolecular switch75, 82. BimKARs contain the 
same components as unimolecular KARs; however, the substrate and PAABD are 
encoded by two separate polypeptides (Fig. 1.2C). One potential advantage of this design 
stems from its tendency to exhibit an increased dynamic range compared to unimolecular 
KARs. This effect is frequently attributed to greater separation of the FPs in the off state.  
Similarly, biosensors that use bioluminescent proteins (BPs) in place of FPs have 
been developed to detect small changes in both a low- and high-throughput fashion in a 
number of different contexts, such as in cell lysates, in single cells and in living animals. 
Bioluminescence is the emission of light by living organisms, mainly marine vertebrates 
and invertebrates, caused by an enzymatic reaction. One class of BPs, commonly referred 
to as luciferases, catalyzes the oxidation of specific substrates known as luciferins to form 
oxyluciferin, along with the concurrent emission of a photon. Many variants of luciferase 
have been described and are characterized by differences in their substrates, the required 
cofactors, the specific wavelength emitted, and the kinetics of emission. However, the 
luciferases most commonly used in the laboratory are derived from the firefly Photinus 
pyralis (FLuc) and the sea pansy Renilla reniformis (RLuc). Free from the need for 
exogenous illumination, bioluminescence-based assays are not subject to interference 
from autofluorescence83-85.  Therefore, luciferases have been exploited and incorporated 
in biosensors that function similarly to FRET-based reporters. Similar to FRET, when a 
luciferase is located in close proximity and with the proper orientation to a fluorophore 
with appropriate spectral overlap, the luminescence generated by luciferase is used to 
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excite the acceptor fluorophore in a phenomenon known as bioluminescence resonance 
energy transfer (BRET). A number of biosensors have been designed that utilize BRET to 
detect various signaling processes, including GPCR and β-arrestin interactions, PKA 
activation, and Ca2+ and cAMP dynamics86-88. The continued development of 
bioluminescence-based assays, which can capture the spatiotemporal patterns of signaling 
events, will expand the molecular toolkit for detecting signaling dynamics and facilitate 
the study of signal transduction in a greater number of settings such as imaging in tissue 
and animal models or high-throughput drug screens. 
 
Significance 
 Throughout this chapter, it has been stressed that the spatiotemporal regulation of 
signaling pathways is important for the proper propagation of specific cellular processes. 
Accumulating evidence has shown that dysregulation of signal transduction pathways can 
lead to some of the most common diseases. In order to tease out the molecular 
mechanisms underlying specificity in signal transduction, applying tools that can capture 
these dynamic events in their native context is necessary. FRET-based reporters have 
become extremely useful tools in detecting various signaling molecules with high 
spatiotemporal resolution, and elucidating new regulatory mechanisms.  With this 
molecular understanding, new approaches can be taken in developing new therapeutic 
strategies for treating diseases such as diabetes, cancer, hypertension and neurological 
disorders.  The first part of the work described herein focuses on the role of 
compartmentalized PKA activity in integrating crosstalk with other signaling pathways to 
regulate specific cell processes. We first elucidate a novel molecular mechanism that 
governs efficient cell migration in confined environment that involves the intricate 
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regulation of PKA activity by both calcium and myosin II signaling pathways. Then, we 
investigate the crosstalk between PKA and Akt at the plasma membrane of PC12 cells to 
decipher how cells regulate the decision to undergo proliferation or differentiation. The 
second portion then describes our efforts to improve genetically encoded biosensors for 
use in drug-screening applications to search for small molecule kinase inhibitors that can 
be utilized to develop new treatments for the diseases mentioned above.  Along these 
same lines, the third part of the work details the generation of a more sensitive FRET-
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INTRODUCTION 
Cells optimize their migratory potential by altering migration modes as they 
encounter different physical microenvironments 89-91. Cells migrating in a mesenchymal 
mode share the typical hallmarks of two-dimensional (2D) planar migration, including 
actin-based membrane protrusion, integrin-dependent adhesion and myosin II-mediated 
retraction. Alternatively, cells can migrate in an amoeboid mode and squeeze through 
narrow channel-like tracks formed between collagen bundles 89 or crawl along linear 
collagen fibers 92. To cope with the physical confinement imposed by these channel- and 
fiber-like tracks, cells adopt mechanisms distinct from those used for locomotion on 
unconfined 2D substratum 89, 90, 93, 94.  
Using microfabricated devices and substrate-printing methods that mimic 
earmarks of the channel- and fiber-like tracks encountered in vivo, researchers have 
identified several key mechanisms that are crucial for cell motility under confinement 95-
98. One of the mechanisms involves the RhoA/myosin II signaling axis 90, 94, 96. In contrast 
to Rac1-dependent migration of many cell types on unconfined 2D surfaces, confined 
migration does not require Rac1-mediated protrusive activities, but instead depends on 
myosin II-driven contractility 90, 94. The contractile forces generated by an actomyosin 
network propel cell locomotion under physical confinement via several strategies 93, 99, 
100. For efficient migration, cells tune the signaling input in different ways to achieve a 
balance between Rac1 and RhoA/myosin II, which leads to a strong Rac1 output by 
unconfined cells and a strong myosin II output by confined cells 94. One unresolved 
question is how cells differentially regulate Rac1 and RhoA/myosin II in response to 
different degrees of confinement. Another important unresolved question is what the 
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underlying mechanosensing mechanism is that allows the cells to respond to physical 
confinement.	  
 Using an α4 integrin-expressing CHO cell model (referred to as CHO-
α4WT cells) that recapitulates aspects of the motile activities of invasive melanoma cells, 
we have reported that CHO-α4WT cells respond to physical confinement by tuning Rac1 
and RhoA/myosin II activities to optimize cell motility 94. Intriguingly, the Rac1 activity 
in CHO-α4WT cells is tightly regulated by cAMP-dependent protein kinase A (PKA), 
which phosphorylates the α4 integrin cytoplasmic tail 101. PKA, a regulator of a wide 
array of physiological functions 102, is also known to play an important role in the 
migration of carcinoma cells and in the regulation of RhoA and Rac1 functions in several 
cooperative pathways 103, These studies, however, have largely focused on cell migration 
on unconfined 2D surfaces. Little is known about how PKA modulates cell migration 
through physically confined spaces.  
 To investigate the role of PKA in confinement-induced mechanosensing and 
signaling optimization, we employed well-established Förster resonance energy transfer 
(FRET)-based PKA activity reporters in conjunction with microfabrication and substrate 
printing technologies to explore the real-time modulation of PKA activity and its 
interaction with relevant signaling networks in response to physical confinement. We also 
examined changes in cell mechanics in response to confinement using atomic force 
microscopy. We demonstrate that efficient cell migration in confined spaces is achieved 
by negative feedback interactions between Ca2+/phosphodiesterase 1 (PDE1)/PKA and 
myosin/Rac1 signaling modules. We also provide evidence for PKA- and myosin II-
mediated confinement-sensing mechanisms. These findings provide a novel mechanism 
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by which cells adapt to different degrees of physical confinement, and optimize their 
motile activities.  
 
RESULTS 
Physical confinement suppresses the phosphorylation levels of α4 integrin in CHO-
α4WT cells.  
 We have reported that α4β1 integrin, ectopically expressed on CHO cells (CHO-
α4WT), promotes cell migration through both unconfined and confined 
microenvironments.  This is achieved by an optimized signaling output that favors Rac1 
activation in unconfined cells versus myosin II-driven contractility in confined cells.  
Because phosphorylation of α4 integrin at Ser988 enhances Rac activity 101, 104, we 
hypothesize that physical confinement negatively regulates α4Ser988 phosphorylation.  
To test this hypothesis, we monitored the extent of α4Ser988 phosphorylation as a 
function of the degree of physical confinement, using a microchannel assay. In this assay, 
CHO-a4WT cells (stably expressing GFP-tagged α4 integrin) were induced to migrate 
toward a chemoattractant source through fibronectin-coated channels of fixed height (10 
µm) and length (200 µm) but with different widths (20 µm, 10 µm, 6 µm, and 3 µm) 
(Fig. 2.1A).  After having migrated into the channels or on an unconfined 2D surface, the 
cells were fixed, stained with an antibody specific for phosphorylated α4Ser988 (referred 
to as phospho-α4Ser988), and imaged by confocal microcopy.  CHO-α4WT cells 
migrating on a 2D surface or inside 20 µm-wide channels displayed strong phospho-
Ser988 staining. However, the level of α4Ser988 phosphorylation gradually diminished 
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Figure 2.1 Effects of physical confinement on α4 phosphorylation.  
(A) Schematic of the microchannel device bounded to glass slide. Also shown below is a 
close-up detail of channel array. Channels of 50-µm, 20-µm, 10-µm, 6-µm, and 3-µm in 
width were used in the study. The red arrow (left to the close-up channel array) indicates 
the direction of migration.  (B) CHO-α4WT and CHO-α4S988A cells were seeded in cell 
seeding area (indicated as unconfined) and then induced to migrate through 20-µm, 10-
µm, 6-µm, or 3-µm fibronectin-coated channels. Cells expressing GFP-α4 integrins were 
stained with phosphorylated α4 (red) and imaged by dual color confocal microcopy.  (C) 
For each designated condition, overall level of α4 phosphorylation is quantified by 
measuring α4 phosphorylation red fluorescence intensity normalized by GFP-tagged α4 
integrin. (D) Schematic representation of microcontact printing. (a and b) PDMS stamp 
(blue) was coated with fibronectin (orange) to be printed. (c) Fibronectin was transferred 
by printing onto cover slide (gray) and then examined by fluorescence staining (d). (E) 
CHO-α4WT and CHO-α4S988A cells placed on either 2D or 1D fibronectin printed 
cover slide were stained with phosphorylated α4 and imaged by confocal microcopy (F) 
The overall α4 phosphorylation level was quantified by measuring α4 phosphorylation 
red fluorescence intensity normalized by GFP-tagged α4 integrin. Data represent means ± 
SEM. *, P < 0.05. 
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with increasing the degree of confinement and reached nearly background levels in 3 µm-
wide channels.  As a control, little or no staining was detected when α4 integrin was 
mutated, substituting Ser988 with alanine (the cells are referred to as CHO-α4S988A, 
also tagged with GFP) (Fig. 2.1B, 1C).  In addition to reduced overall phospho-α4Ser988 
levels, the spatial staining pattern of phospho-α4Ser988 was also altered, and became 
bipolar as the channel width decreased from 20 µm to 10 µm or less (Fig. 2.1B).    
 Cells utilize myosin IIA to promote efficient migration on 1D printed lines98. This 
mechanism shares similarities with migration inside narrow microchannels94. Thus, we 
examined the change of α4Ser988 phosphorylation levels in response to lateral 
confinement resulting from adhesion/spreading constraints, by generating 1D 8µm-wide 
fibronectin-printed lines where cells were allowed to attach and assume an elongated 
morphology (Fig. 2.1D, E).  Similar observations with respect to α4Ser988 
phosphorylation were noted between cells on 1D printed lines and inside narrow 
channels.  Specifically, CHO-α4WT cells on 1D fibronectin-coated lines exhibited 
significantly lower α4Ser988 phosphorylation levels than cells on 2D fibronectin-coated 
surface (Fig. 2.1E, F).  These data reveal that physical confinement down-regulates 
α4Ser988 phosphorylation in CHO-α4WT cells.  Taken together, the cells are capable of 
modulating their α4Ser988 phosphorylation levels in response to confinement. 
 
Differential modulation of PKA activity is required for optimized migration of 
CHO-α4WT cells through unconfined versus confined spaces   
 α4Ser988 is phosphorylated by PKA101.  Because confinement alters α4Ser988 
phosphorylation levels in CHO-α4WT cells, we hypothesize that PKA activity is 
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differentially regulated in unconfined versus confined cells in order to optimize their 
migration in distinct microenvironments.  As a first step, we examined the effects of a 
PKA inducer, forskolin, and a PKA inhibitor, Rp-cAMPs, on cell migration as a function 
of the degree of physical confinement, using our microchannel assay. CHO-α4WT cells 
treated with forskolin (50 µM) migrated as efficiently as vehicle controls in wide (50 or 
20 µm) channels, but displayed a markedly reduced velocity in narrow (10, 6 or 3 µm) 
channels.  In contrast to forskolin, PKA inhibition using Rp-cAMPs (50µM) had the 
opposite effect.  Cells migrated efficiently in narrow channels but with significantly 
lower velocity relative to vehicle control in wide channel (Fig. 2.2A, B).  Because 
α4Ser988 phosphorylation is suppressed in CHO-α4WT cells when confined in narrow 
channels or on narrow 1D printed lines, we next tested the effects of PKA modulation on 
CHO-α4WT cells migrating on 8 µm-wide fibronectin-coated lines compared to those on 
2D fibronectin-coated surfaces.  In accord with our microchannel data, induction of PKA 
activity using forskolin (50 µM) suppressed both the velocity and instantaneous speed in 
cells migrating on 1D fibronectin-printed lines.  In contrast, inhibition of PKA activity 
using Rp-cAMP enhanced 1D cell migration (Fig. 2.2C-E).  Using forskolin and Rp-
cAMP, we also demonstrate that PKA activity inhibits myosin II-dependent assembly of 
stress fibers and focal adhesion density but enhances Rac1-dependent cell spreading in 
both CHO-α4WT and parental CHO cells (Fig. 2.3). Taken together, low PKA activity is 
required for optimal migration of CHO-α4WT cells in confined spaces, whereas high 
PKA activity is necessary for efficient cell migration in unconfined microenvironments. 
We propose that the cells are capable of tuning the level of PKA activity in response to  
different degree of physical confinement. 
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Figure 2.2 Effects of inhibiting or enhancing PKA activity on confined migration 
and 1D migration of CHO-α4WT cells.  
CHO-α4WT cells were treated with either PKA enhancer forskolin, PKA inhibitor Rp-
cAMPs, or vehicle control and allowed to migrate inside of fibronectin-coated channel (A 
and B) or on fibronectin printed 8µm wide 1D pattern (C, D, and E). Their migration 
velocities (A and D) and instantaneous speed (E) were quantified. The time-lapse images 
of migrating cells in designated channel widths (B) and 1D pattern (C) are shown. Data 
represent means ± SEM. *, P < 0.005. 
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Figure 2.3 Effects of modulation of PKA activity on focal adhesion and stress fiber 
densities and spreading of CHO-α4WT and CHO cells. CHO-α4WT or CHO cells 
were plated on fibronectin-coated coverslips in presence of vehicle control, the PKA 
inhibitor Rp-cAMPs, or the PKA inducer forskolin. (A and D) Cells stained with 
phalloidin (green) and with an antibody specific for paxillin (red) were imaged by 
confocal microcopy. To evaluate myosin II activity, focal adhesion densities were 
quantified as the ratio of the total area of focal adhesions to the cell spreading area. Stress 
fiber densities were also quantified as the ratio of the total area of stress fibers to the cell 
spreading area (B and E). Cell spreading (C and F) was also quantified by image 
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Physical confinement suppresses PKA activity  
 To test the hypothesis that PKA activity is differentially regulated in unconfined 
versus confined spaces, we utilized a FRET-based PKA activity biosensor (AKAR4) to  
measure PKA activity levels in unconfined and confined CHO-α4WT cells.  PKA 
activity is detect as an increase in FRET ratio (yellow-to-cyan emission upon CFP 
excitation) due to PKA phosphorylation0induced conformational change of the sensor.  
To assess plasma membrane-localized PKA activity we used a plasma membrane-
targeted version of AKAR4, AKAR4-Kras72 (Fig. 2.4A).  AKAR4-Kras was transiently 
transfected into CHO-α4WT cells, and the initial FRET ratio (yellow-to-cyan emission 
ratio) prior to drug treatments was obtained to quantify the basal levels of plasma-
membrane PKA activity (referred to as PKA activity hereafter). Unconfined cells 
exhibited higher initial FRET ratio compared to confined cells (Fig. 2.4B, E), indicating 
that confined cells had lower basal PKA activity than unconfined cells.  As a control, we 
showed that the FRET ratio did not significantly correlate with transfection efficiency 
(Fig. 2.4F). To substantiate the reduction of PKA activity observed in confined cells, we 
quantified the effects of the PKA inhibitor H89 (10 µM) in unconfined and confined 
CHO-α4WT cells.  A smaller reduction of FRET ratio is indicative of a lower basal PKA 
activity.  Indeed, after 30 min of cell treatment with H89, unconfined cells exhibited a 
pronounced reduction (20.6±4.2%) in FRET ratio whereas only a modest decrease 
(7.0±1.2%) was detected in confined cells (Fig. 2.4B-C).  Taken together, these data 
indicate that confined CHO-α4WT cells possess lower basal PKA activity levels than 
unconfined cells.  Along these lines, a decrease in PKA activity levels is observed as cells  
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Figure 2.4 Confinement suppresses PKA activity. 
(A) Schematic diagram of AKAR4-Kras biosensor. The biosensor is composed of a 
substrate peptide, cpVE172 and the phosphoamino-binding domain (FHA1), each tagged 
with a fluorescent protein, and the membrane targeting motif CAAX. (B) CHO-α4WT 
cells expressing AKAR4-Kras were plated on unconfined spaces or induced to migrate 
into 3µm channel to experience confinement. YFP and FRET ratiometric images of 
confined and unconfined cells before the PKA inhibitor H89 was added (0 min) and at 15 
and 30 min after the addition. (C) Representative curves of normalized PKA activity of 
CHO-α4WT cells in confined or unconfined microchannels after addition of H89. Bar 
graph represents the percentage of decay of PKA activity at 30 min after addition of H89. 
(D) Time-lapse FRET ratiometric images of a CHO-α4WT cell expressing AKAR4-
KRAS, as the cell is migrating from an unconfined area into a 3µm channel. (E) The 
basal PKA activities of confined and unconfined CHO-α4WT, CHO, and CHO-B2 cells. 
The basal PKA activities (Y/C) of CHO-α4WT (F), CHO (G), and CHO-B2 (H) cells 
were plotted against YFP intensity index, which represents the transfection efficiency of 
AKAR4-Kras. Linear regression was performed to evaluate the correlation of PKA 
activity and YFP intensity index in confined and unconfined cells. P-value and R-squared 
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transition from an unconfined two-dimensional surface to a narrow (3 µm in width) 
channel  (Fig. 2.4D). 
 We have previously shown that an invasive melanoma cell line, A375-SM, 
responds to confinement in a similar manner as CHO-α4WT cells 94. Both cell types 
optimize cell motility by modulating Rac1 and myosin II in unconfined and confined 
spaces 94. Along these lines, we found that A375-SM cells tune PKA activity similarly to 
CHO-α4WT cells for efficient migration in unconfined and confined spaces (Fig. 2.5). 
α4 and α5 integrins have been reported to play important roles in the 
spatiotemporal regulation of PKA in order to stimulate CHO cell migration on 2D 
substrates105.  We thus investigated if the reduced PKA activity in confinement is 
mediated by α4 and/or α5 integrins. To this end, we quantified the basal PKA activity 
levels in three cell lines: CHO-α4WT that expresses both α4 and α5 integrins, parental 
CHO that only expresses α5 integrin and CHO-B2 that lacks α4 and α5 integrins106, 107. 
Interestingly, physical confinement significantly suppresses PKA activity in all three cell  
lines (Fig. 2.4E), suggesting that α4 and α5 integrins are not required for the differential 
levels of PKA activity in unconfined versus confined cells.  As a control again, we also 
showed that the FRET ratio did not significantly correlate with transfection efficiency 
(Fig. 2.4G-H). However, it is noteworthy that the expression of α4 and α5 integrins 
elevates the basal levels of PKA activity in both unconfined and confined cells.  
Collectively, these results indicate that although α4 and α5 integrins enhance the overall 
PKA activity, they are not required for the cells to sense and respond to physical 
confinement.	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Figure 2.5 Effects of confinement on PKA-modulated migration of A375-SM 
melanoma cells. (A) YFP and FRET ratiometric images of confined and unconfined 
A375-SM melanoma cells expressing AKAR4-Kras. (B) Integrated dot/box plot 
comparing the basal PKA activities of unconfined and unconfined A375-SM cells. (C) 
A375-SM cells were treated with either the PKA inhibitor Rp-cAMP or the PKA inducer 
forskolin or appropriate vehicle control, and induced to migrate inside fibronectin-coated 
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Elevated intracellular calcium in confined cells negatively regulates PKA via PDE1  
In light of prior work showing the role of calcium in cell migration, and the 
presence of negative crosstalk between calcium and PKA58, we hypothesize that 
the changes in PKA activity induced by physical confinement are regulated via Ca2+-
dependent signaling mechanisms.  To test this, we used a FRET-based Ca2+ indicator, 
Yellow Cameleon 3.6 (YC 3.6) to monitor intracellular Ca2+ levels in both unconfined 
and confined CHO-α4WT cells (Fig. 2.6A)108.  Upon Ca2+binding, the CaM-M13 
molecular switch undergoes a conformational change, thereby resulting in a FRET ratio 
increase.  Confined compared to unconfined CHO-α4WT cells exhibited lower basal 
Ca2+ levels (Fig. 2.6, C). To investigate the potential source of higher basal Ca2+ levels in 
confined cells, we treated CHO-α4WT with the stretch-activated cation channel inhibitor 
GsMTx4 109. This treatment suppressed the Ca2+ levels in confined cells down to those of 
unconfined cells (Fig. 2.6C). Moreover, GsMTx4 failed to alter the Ca2+ levels in 
unconfined cells (Fig. 2.6C). Taken together, these data suggest that physical 
confinement elevates intracellular Ca2+ via stretch-activated ion channels. 
To directly assess the effect of Ca2+ on PKA, we measured PKA activity in CHO-
α4WT cells transfected with AKAR4-Kras in the presence or absence of the Ca2+ chelator 
BAPTA-AM (40 µM).  An increase in PKA activity was detected in confined cells 
following BAPTA treatment (Fig. 2.6D).  This response is attributed to the higher 
intracellular calcium levels in resting confined cells, which greatly suppresses PKA 
activity.  On the other hand, no significant change was noted in unconfined cells under 
BAPTA treatment (Fig. 2.6D), which is consistent with the unconfined cells having low  
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Figure 2.6 Calcium modulates PKA activity via PDE1  
(A) Schematic diagram of FRET-based Calcium indicator, Yellow Cameleon (YC3.6) 
(B) YFP and FRET ratiometric images of confined and unconfined CHO-α4WTcells 
expressing YC3.6. (C) The basal Calcium levels of confined or unconfined CHO-α4WT 
cell treated with either the stretch-activated ion channels inhibitor GsMTx4 (10 µM) or 
vehicle control are quantified by measuring the initial FRET (i.e. yellow-to-cyan ratio). 
(D) Representative curves of normalized PKA activity in unconfined (N=7) and confined 
(N=5) CHO-α4WT expressing AKAR4-KRAS, treated with BAPTA at time 0 min. 
Corresponding bar graph shows the increase of PKA activity after 5 min of drug 
treatment. (E) Representative curves of normalized PKA activity in unconfined and 
confined CHO-α4WT expressing AKAR4-KRAS, treated with IBMX. Corresponding bar 
graph shows the increase of PKA activity after 5 min of drug treatment. (F) Changes in 
PKA activity in unconfined and confined CHO-α4WT cells after treatment with PDE1, 
PDE3, and PDE4 inhibitors, respectively. (G) CHO-α4WT cells treated with the PDE1 
inhibitor or vehicle control were compared for differential PKA activities in unconfined 
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basal intracellular calcium levels.  Along these lines, treatment of CHO-α4WT cells with 
the stretch-activated cation channel inhibitor GsMTx4 suppressed the high Ca2+ level in  
confined cells down to that of unconfined cells (Fig. 2.6C).  Moreover, GsMTx4 failed to 
alter the Ca2+ level in unconfined cells.  Taken together, these data reveal that physical 
confinement elevates intracellular calcium via stretch-activated ion channels, to suppress 
PKA activity. To delineate the mechanism underlying Ca2+-mediated suppression of PKA 
activity in confined cells, we investigated the potential contribution of PDEs, which are 
enzymes that down-regulate PKA by hydrolyzing cAMP.  As a first step, cells transfected 
with AKAR4-Kras were treated with a general PDE inhibitor 3-isobutyl-1-
methylxanthine (IBMX; 100 µM)46.  Both unconfined and confined cells treated with             
IBMX displayed an increase in PKA activity (Fig. 2.6E), thereby demonstrating the 
presence of basal PDE activity in CHO-α4WT cells and the inhibitory effect of PDEs on 
PKA.  Notably a significant difference in the amplitude of the AKAR4-Kras response 
was observed between unconfined and confined cells following treatment with IBMX 
(Fig. 2.6E, G).  The larger increase in PKA activity in confined cells in response to 
IBMX indicates that confined cells exhibit higher PDE activity than unconfined cells, 
which contributes to their differential basal PKA activity levels.  
We next wished to identify the PDE responsible for regulating Ca2+-mediated 
suppression of PKA activity in confined cells.  Certain PDEs, such as PDE1 and PDE4, 
are specifically upregulated by Ca2+110.  The distinguishing feature of PDE1 is its 
regulation by Ca2+/calmodulin through direct interactions. Another potential Ca2+-
mediated regulator of PKA activity is PDE4 due to a phosphorylation-dependent 
activation by Ca2+/calmodulin-dependent protein kinase II (CaMKII)111. Cell treatment 
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with the PDE4 specific inhibitor rolipram (10 µM) elicited a similar increase in PKA 
activity in both unconfined and confined cells (Fig. 2.6F). These results indicate that, 
although PDE4 contributes to the suppression of basal PKA activity, it does not exert a 
differential effect in response to physical confinement. In contrast, cell treatment with a 
PDE1 selective inhibitor 8 methoxy methyl IBMX (8MM-IBMX, 100µM) caused a 
pronounced increase in PKA activity levels in confined cells, whereas only a modest 
increase was noted in unconfined cells (Fig. 2.6F, G) indicating that PDE1 contributes to 
the confinement-dependent PKA suppression. As a control, we inhibited a non-Ca2+-
dependent PDE, PDE3, with milrinone (1 µM) and monitored the FRET response from 
AKAR4-Kras. As predicted, there was no detectable enhancement in PKA activity in 
either unconfined or confined cells, indicating that PDE3 is not involved in regulating 
PKA activity in response to changes in intracellular Ca2+ and physical confinement (Fig. 
2.6F). Taken together, our data provide clear evidence that the differential PKA 
regulation in response to confinement is Ca2+-dependent and proceeds mainly through 
PDE1.  
 
PKA and myosin II form a double negative feedback loop 
 Because Rac1 and myosin II play key roles in optimizing cell motility in 
unconfined and confined spaces 94, we tested if their activities are affected by modulating 
PKA activity. We found that, in both CHO-α4WT and parental CHO cells, Rp-cAMP 
enhanced myosin II-dependent assembly of stress fibers and focal adhesion density but 
reduced Rac1-dependent cell spreading, whereas forskolin had the opposite effects (Fig. 
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2.3). These data show that Rac1 and myosin II act as downstream effectors of the 
Ca2+/PDE1/PKA pathway.  
 Myosin II acts not only as a downstream PKA effector but also as an upstream 
regulator of PKA. This conclusion is substantiated by data showing that inhibition of 
myosin II by blebbistatin (50 µM) caused a significant increase in PKA activity of both 
unconfined and confined CHO-α4WT and parental CHO cells relative to vehicle control 
(Fig. 2.7A, A’, B, and B’). Rac1 is known to activate A-kinase anchoring proteins 
(AKAPs) that in turn recruit and activate PKA at the leading edge of migrating cells 112, 
113. Due to the interaction between Rac1 and myosin II, myosin II may negatively 
regulate PKA activity via a Rac1-dependent pathway. To test this possibility, CHO cells 
were treated concurrently with blebbistatin (50 µM) and the Rac1 inhibitor NSC23766 
(20 µM). This dual treatment abolished the enhancing effect of blebbistatin on the PKA 
activity of both unconfined and confined cells (Fig. 2.7B, C), thereby indicating that 
myosin II down-regulates PKA activity through a Rac1-dependent pathway.  
 In view of these data (Fig. 2.7 and 2.3), we propose that PKA modulates the 
activities of myosin II and Rac1, and myosin II further tunes the activity of PKA via 
Rac1. These interactions establish a negative feedback loop, which ultimately leads to an 
optimized balance between Rac1 and myosin II and efficient cell motility in different 
degree of physical confinement. 
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Figure 2.7 Myosin II modulates PKA activity via Rac1.  
(A and A’) Unconfined (A) and confined (A’) CHO-α4WT and CHO cells expressing 
AKAR4-Kras were treated with blebbistatin or vehicle control. The arrows indicate the 
high PKA activity at the leading edge of cells. (B and B’). The PKA activities in 
unconfined (B), and confined (B’) CHO-α4WT and CHO cells with each indicated 
treatments were quantified and graphed. (C) Untreated CHO-α4WT or CHO cells were 
compared with cells under designated drug treatments for changes in PKA activity in 
response to confinement. (D) Integrated dot/box plots for comparing the basal PKA 
activities in unconfined versus confined CHO-α4WT or CHO cells in the presence or 
absence of concurrent treatment with blebbistatin and 8MM-IBMX. Data represent the 
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PDE1 and myosin II inhibitors synergistically abrogate confinement-induced PKA 
suppression 
 Our finding that elevation of intracellular Ca2+ in response to confinement 
depends on stretch-activated ion channels implicates a confinement-sensing pathway 
mediated by the Ca2+/PDE1/PKA signaling module. We reasoned that, if 
Ca2+/PDE1/PKA is the sole confinement-sensing mediator, then inhibition of PDE1 
should abrogate the differential PKA activity in unconfined versus confined cells. 
However, treating CHO-α4WT cells with the PDE1-selective inhibitor 8MM-IMBX  
suppressed but failed to abolish the confinement-induced differential PKA activity 
(Figure 2.6G), suggesting that cells can sense confinement via an alternative pathway 
independent of PDE1. 
 External forces have been reported to induce assembly of myosin II bi-polar 
filaments and actomyosin bundles 114, 115. This force-sensitive activity of myosin II led us 
to hypothesize that myosin II may also mediate confinement-sensing, thereby leading to a 
cascade of signaling events that ultimately suppress PKA. To test this possibility, we 
treated CHO-α4WT cells with blebbistatin alone or with blebbistatin and the Rac1 
inhibitor NSC23766. These treatments failed to abolish the difference in the PKA activity 
of unconfined versus confined cells (Fig. 2.7C), indicating that the myosin II/Rac1 
pathway is dispensable for confinement-induced PKA suppression. However, 
simultaneous treatment with blebbistatin and the PDE1 inhibitor 8MM-IBMX effectively 
abrogated the confinement-induced suppression of PKA activity in both CHO-α4WT and 
parental CHO Cells (Fig. 2.7E). The synergistic effect of this dual inhibition reveals the 
existence of two confinement-sensing pathways, one is mediated by the Ca2+/PDE1/PKA 
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pathway, and the other by the myosin II/Rac1 pathway.  Each of these confinement-
sensing pathways can act independently in the absence of the other. 
 
PDE1 and myosin II inhibitors synergistically abrogate confinement-induced 
enhancement of cell stiffness  
To further understand how cells respond to physical confinement, we also 
evaluated the ability of cells to resist deformation (referred to as cell stiffness) in 
response to confinement simulated using 1D fibronectin-coated lines. Specifically, we 
employed atomic force microscopy to measure the elastic modulus by indenting a cell 
with an AFM cantilever tip. The applied force was calculated from the degree of bending 
(deflection) of the cantilever as a function of indentation position of the AFM tip, using 
the Sneddon/Hertz model 116 (Fig. 2.8A,B). We investigated the effects of confinement 
on the stiffness of CHO-α4WT and parental CHO cells plated on fibronectin-coated 2D 
unconfined surfaces and narrow 1D fibronectin-printed lines (Fig. 2.8B). The results 
indicate that cells on 1D lines displayed a markedly higher stiffness compared to cells on 
a 2D surface (Fig. 2.8C).  
Remarkably, perturbing either myosin II or the optimally tuned activity of PKA 
significantly affected cell stiffness (Fig. 2.8D): inhibition of myosin II activity using 
blebbistatin suppressed cell stiffness (Fig. 2.8C), whereas inhibition of PKA using Rp-
cAMPs or induction of it via forskolin enhanced or repressed cell stiffness, respectively 
(Fig. 2.8D). These results indicate that cell stiffness is regulated by PKA and myosin II. 
Next, we asked if the PKA- and myosin II-dependent pathways contribute to the sensing 
capability of the cells that allow the cells to differentially regulate the stiffness in  
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Figure 2.8 Confinement enhances cell stiffness.  
(A) Schematic diagram of atomic force microscopy (AFM) technique used for measuring 
cell stiffness. (B) Representative approach curves from parental CHO cells cultured on 
2D or 1D fibronectin-printed surfaces showing deflection (degree bending of AFM 
cantilever) as a function of indented position. (C, D) Bar graphs represent the elastic 
modulus (stiffness) of parental CHO and CHO-α4WT cells for each designated 
condition, calculated from the approach curves. Data represent the mean±SEM for n>35 
cells for each condition. *, p<0.05. (E) Integrated dot/box plots comparing stiffness of the 
cells plated on 1D versus 2D fibronectin-printed patterns in the presence or absence of 
concurrent treatment with blebbistatin and 8MM-IMBX. 
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response to confinement. While perturbing PKA, PDE1 or myosin II alone did not 
abolish confinement-induced enhancement of cell stiffness on 1D compared to 2D 
printed lines (Fig. 2.8C,D), dual inhibition of myosin II and PDE1 effectively abrogated 
the difference in cell stiffness between the two conditions (Fig. 2.8E). These data support 
the existence of two independent confinement-sensing mechanisms mediated by the 
Ca2+/PDE1/PKA and myosin II/Rac1 signaling modules, respectively. 
 
DISCUSSION 
Combining FRET-based biosensors, a microfabricated device, and AFM, we 
delineated the mechanism by which physical confinement is sensed and responded to by 
CHO-α4WT cells.  Based on our current data and those reported in the literature, we 
propose a new model where confinement signals sensed by two separate pathways are 
integrated through a double-negative feedback loop, resulting in optimal circuit activity 
for efficient cell migration (Figure 2.8).   
 
There are two independent confinement-sensing mechanisms 
We show that confinement-induced suppression of PKA and enhancement of cell 
stiffness are not abolished when cells are treated with a PDE1 inhibitor or blebbistatin 
alone, but treating the cells simultaneously with both inhibitors abrogates the 
confinement-induced effects. Therefore, there are two confinement-sensing mechanisms, 
one is mediated by the Ca2+/PDE1/PKA pathway, and the other by the myosin II/Rac1 
pathway; each pathway can elicit cell responses to confinement. Having two sensing  
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Figure 2.9 Proposed negative feedback signaling loop that promotes migration of 
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mechanisms could enhance the sensitivity of the cells to confinement and increase the 
range of confinement signals to be sensed.  Because myosin II senses confinement signal 
and also directly contributes to migratory activities, it “short-cuts” the 
mechanotransduction circuit, which may fasten the response of the cells to confinement. 
It is known that integrins play a pivotal role in mechanosensing 117. However, we 
show that α4 and α5 integrins are dispensable for cells to sense confinement and 
suppress PKA activity. In addition, synergy and compensation are not observed between 
α4 integrin and PDE1 or myosin II. These observations are consistent with the notion that 
in confined environment integrin-mediated cell adhesion becomes less important for cell 
motility 97, 118, and confined migration favors low adhesion 90. We show that, although not 
contributing to confinement-sensing, α4 integrins do participate in PKA regulation in a 
confinement-independent manner, which supports the AKAP function of α4 integrins as 
reported in the literature 54.   
Collectively, our data reveal that the Ca2+/PDE1/PKA and myosin II/Rac1 
signaling modules, but not α4 integrins, act as mediators for confinement-sensing. 
Further studies are necessary to elucidate the confinement-sensing mechanisms. We show 
that, when treated with a stretch-activated cation channel (SAC) blocker, cells fail to 
increase their intracellular Ca2+ level in response to confinement. This finding implicates 
SACs in confinement-sensing. When cells are compressed by confinement, SACs could 
be activated by tension generated by deformation of the lipid bilayer and the stretching 
force from cortical actomyosin network. But, given that cells can sense confinement 
when myosin II is inhibited, SACs could be activated via both myosin II-dependent and 
independent mechanisms. Besides SACs, myosin II may also act as a mechanosensor by 
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facilitating force-sensitive assembly of myosin II bi-polar filaments 114, 115. Myosin II 
may also mediate confinement-sensing by activating cytoskeletal mechanosensors 119. 
Future work should be directed toward determining if these mechanisms facilitate 
confinement sensing.   
 
PKA and Myosin II amplifies circuit activity via a double negative feedback system  
We demonstrate that, in response to confinement, PKA and myosin II form a 
double negative feedback loop. In CHO-α4WT cells, confinement-induced suppression 
of PKA leads to decreased PKA-dependent phosphorylation of α4 integrin, which 
promotes the formation of an α4/paxillin/GIT1 complex that inhibits Rac1, thus 
enhancing myosin II activity 94, 120. In parental CHO cells, PKA also regulates Rac1 and 
myosin II independent of α4 integrin, which is likely due to direct inhibitory effects of 
PKA on RhoA and Rho-GEF 121, 122. Our data indicate that, myosin II acts not only as a 
downstream PKA effector, but also as an upstream regulator that suppresses PKA 
activity. The suppression depends on Rac1. Several Rac1 effectors, including WAVE1 
and WAVE2, function as AKAPs that recruit and activate PKA at the cell cortex 
proximal to the plasma membrane 112, 113. Therefore, the activity of membrane-associated 
PKA could be affected by inhibition of the Rac1/WAVEs pathways. Thus, PKA and 
myosin II/Rac1 form a double negative feedback loop. Because it is known that calcium 
may directly enhance myosin II via calmodulin-mediated pathways 123, and myosin II-
driven contractility plays a key role in activation of stretch-activated ion channels 124, the 
signaling circuit could be more complex. The presence of double-negative feedback may 
allow this circuit system to respond to physical confinement with ultrasensitivity and 
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even exhibit switch-like behaviors. As a consequence, small changes in the physical 
environment may flip the PKA-Myosin II switch, leading to a new balance between 
Myosin II and Rac1 activities, thereby optimizing the efficiency of cell motility. This 
double negative feedback mechanism provides a novel strategy for signal optimization.  
We extended our observations by demonstrating confinement-induced 
suppression of PKA activity in an invasive melanoma cell line, A375-SM. Optimal 
modulation of PKA activity is necessary for A375-SM cells to migrate efficiently in 
unconfined and confined spaces. These results are consistent with our previous findings 
showing that A375-SM cells modulate Rac1 and myosin II in response to physical 
confinement in a similar manner as CHO-α4WT cells 94. Therefore, the 
mechanotransduction signaling mechanism uncovered in this work provides novel 
insights into how cells sense and adapt to microenvironments with different degrees of 
physical confinement, and optimize their motile activities.  
 
MATERIALS AND METHODS 
Cell culture, pharmacological inhibitors, plasmids and transfection 
CHO-α4WT and CHO-α4S988A cell lines were generated by stably transfecting 
CHO cells with pQN4G and pQN4S988AG plasmids, respectively, in which wild-type or 
mutant α4 integrin cDNA was tagged with GFP by inserting into a PGBI25-fN1 GFP 
vector 125, 126. The CHO-α4WT cells were maintained in Ham’s F12 (Cellgro). CHO and 
CHO-B2 (ref: Schreiner) cells were maintained in DMEM (high glucose, Life 
technology) and minimal essential medium (Invitrogen), respectively. Media were 
supplemented with 10% fetal bovine serum (FBS, Gibco) and 1 µg/ml 
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penicillin/streptomycin. For studies with pharmacological agents, 50 µM forskolin (Santa 
Cruz), 50 µM Rp-cAMPs (Santa Cruz), or appropriate vehicle controls were added to the 
cells seeded in serum-free medium near microchannel entrances. For PKA study, 3-
isobutyl-1-methylxanthine (IBMX), 8 methoxy methyl IBMX (8MM-IBMX) rolipram 
(Cayman Chemical), and milrinone (Enzo Life Sciences) were used to probe basal PKA 
activity. Transient transfection was performed using Lipofectamine 2000 (Life 
Technologies) according to the manufacturer’s protocol. 
Microfluidic-based microchannel assay 
PDMS microchannels were fabricated using standard replica molding. Masks to generate 
the microchannel design were drawn using Adobe Illustrator CS2 and printed onto a 
transparency by a 5080 dpi printer (Pageworks) or transferred to a chrome-on-glass 
photolithography mask (Advance Reproductions Corp.). To prepare masters, SU-8 2010 
and SU-8 2025 epoxy negative photoresists (Microchem Corp.) were applied by spin 
coating (Laurell Technologies Corp.) onto silicon wafers (Montco Silicon Technologies 
Inc.) in two steps. SU-8 2010 was first spread at 600 rpm for 20 s and then at 4000 rpm 
for 60 s to a final thickness of 8-10 µm. The photoresist was prebaked at 60 °C for 1 min, 
exposed to UV (350−450 nm) radiation through appropriate masks for 40 s, postbaked at 
115 °C for 8 min, and subsequently developed using SU-8 developer (Microchem Corp.). 
This step was used for generating the microchannels present in the final device. The 
second feature of the microfluidic-based microchannel master consisted of the cell 
seeding line and the FBS gradient generation line, and was fabricated using the following 
steps: SU-8 2025 was first spread at 500 rpm for 10 s and then at 4000 rpm for 30 s to a 
final thickness of 50 µm. The photoresist was prebaked at 80 °C for 3 min and at 110 °C 
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for 6 min, cooled, and exposed to UV (350−450 nm) radiation for 30 s through a mask 
aligned with the previously fabricated microchannels. The photoresist was then exposed 
for 8 min at 110 °C and developed as before. PDMS stamps were obtained by mixing 
Sylgard 184 prepolymer with cross-linker (Dow Corning) in a 10:1 ratio (by weight), 
degassing in a vacuum, and curing at 80 °C for 1 h. Each PDMS well inlet and outlet was 
punched out with a diameter of 6 mm. Both the PDMS device and microscope slide 
(FisherFinest) were cleaned and made hydrophilic using a plasma cleaner for 2 min. The 
PDMS device was then attached to a glass slide, followed by pre-coating various 
concentrations of 20µg/ml fibronection at 37 °C for 1 h. The microchannel was washed 
with PBS (1X) containing calcium/magnesium for 1 min before seeding cells. A total of 
1x105 cells in a 50 µl volume were added to the cell inlet port. Chemotactic-driven cell 
migration was recorded via time-lapse microscopy (inverted Eclipse Ti microscope, 
Nikon) using software controlled stage automation (Nikon). To calculate migration 
velocity, the cell center was identified as the midpoint between poles of the cell body, 
and was tracked for changes in X, Y position at 20-min intervals over a 10 h period. 
 
Fabrication of 1D Protein Micropatterns 
Standard lithography was used to create a silicon wafer with an array of features that are 
50µm wide, 5µm tall, and 20mm long, with 8µm in between adjacent features. Replica 
molding was used to create a PDMS stamp bearing the inverse of these features. PDMS 
stamps were sonicated in ethanol and dried under an air stream. Stamps were 
functionalized with 100µg/mL Fibronectin (Sigma-Aldrich, F-0895) in Dulbecco’s 
Phosphate Buffered Saline (PBS) (Life Technologies, 14190-144). After one hour at 
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room temperature, this solution was removed and the stamps were again dried under an 
air stream. Stamps were then inverted onto tissue culture dishes (Falcon, 353002) under 
steady pressure. After 30 minutes, the stamps were removed and the dish was backfilled 
with 2.5%wt Bovine Serum Albumin (Sigma-Aldrich, A9647) in PBS to prevent cell 
adhesion outside of the fibronectin-patterned areas. After one hour the BSA solution was 
removed and the stamps were rinsed three times with PBS. 2D areas were created using a 
flat PDMS stamp according to the same procedure. 
 
AKAR4-Kras, Yellow Cameleon 3.6 (YC 3.6), and PKA activity Imaging 
Cells transfected with biosensors, AKAR4-Kras or Yellow Cameleom were washed twice 
with Hanks’ balanced salt solution buffer and maintained in the dark at room 
temperature. Transfected cells were imaged on a Zeiss Axiovert 200M microscope with a 
cooled charge-coupled device camera (MicroMAX BFT512, Roper Scientific, Trenton, 
NJ) controlled by METAFLUOR 6.2 software (Universal Imaging, Downingtown, PA). 
Dual cyan/yellow emission ratio imaging used a 420DF20 excitation filter, a 450DRLP 
dichroic mirror, and two emission filters [475DF40 for CFP and 535DF25 for YFP]. 
These filters were alternated by a filter-changer Lambda 10–2(Sutter Instruments, 
Novato, CA). Exposure time was 50–500 ms, and images were taken every 10–30 s.  
Fluorescence images were background-corrected by subtracting the fluorescence intensity 
of background with no cells from the emission intensities of cells expressing fluorescent 
reporters. The ratios of yellow/cyan emissions were then calculated at different time 
points. The values of all time courses were normalized by dividing each by the average 
basal value before drug addition, 
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Atomic force microscopy and stiffness measurement 
Force spectroscopy experiments were conducted using a Molecular Force Probe 
(MFP-1D; Asylum Research, Santa Barbara, CA). Using thermal oscillation method, a 
triangular cantilever (nominal spring constants of 10 pN/nm) was calibrated, with its 
deflection (degree of bending) measured by laser reflection onto a split photodetector127, 
128. CHO-α4WT or CHO cells were seed on the glass slide patterned with 8µm 
fibronectin line or uniform fibronectin 2D surface. Cells were cultured in serum-free 
desired medium solution with 50µM blebbistatin, 50µM forskolin, 50µM Rp-cAMPs or 
appropriate vehicle control. The cantilever height was adjusted such that each approach 
cycle generated a slight force (~1–2 nN) onto the cell surface before reproach. For each 
run, reproach velocity was 25 mm/s, and the dwell time was set to 20 ms. Stiffness was 
analyzed and quantified as previously described116. Briefly, the point of contact between 
the AFM tip and the cell surface was identified by a custom MATLAB program. The 
positions of the AFM tip were measured during the approach and retraction cycle and 
recorded by a photodiode. The approaching curve (deflection as a function of indented 
position) was then fitted by Hertz model for corresponding tip geometry,.  The Sneddon 
model of indentation force was used to calculate the elastic modulus (i.e. the stiffness) of 
the cell from the shape of this curve.   
 
Statistical analysis 
Data are expressed as mean ± SEM. Statistical significance of differences 
between means was determined by Student’s t-test or one-way ANOVA followed by the 
Tukey test for multiple comparisons, where appropriate.  
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INTRODUCTION 
The PC12 cell line was derived from a rat pheochromocytoma, a tumor arising 
from chromaffin cells of the adrenal medulla. A unique feature of PC12 cells is their 
distinct responses to different growth factors. Specifically, NGF signaling through the 
receptor tyrosine kinase (RTK), TrkA, causes differentiation, while another RTK 
activated by EGF can stimulate proliferation. Although the responses to both NGF and 
EGF require ERK activation, when stimulated with EGF, ERK exhibits a rapid and 
transient activity pattern mediated by both Ras and Rap1, while NGF stimulation of ERK 
leads to both rapid and sustained signaling through Rap1 alone. PC12 cells have since 
become a model system for studying cell differentiation, as well as how different 
signaling dynamics can lead to distinct biological outcomes.   
RTKs are known to recruit and activate a host of downstream signaling 
molecules, including additional docking proteins129, and a variety of signaling pathways 
have been shown to interact with components of the MAPK/ERK pathway, which may 
provide a possible mechanism for these specific growth-factor induced cellular processes. 
For example, PKA can activate Rap1, B-Raf and subsequently ERK via tyrosine kinase 
Src130. Others have shown that cAMP signals via both Epac and PKA to tune ERK 
activity and thus the cellular response21, 29. Furthermore, other studies have focused on 
the cross-talk between ERK signaling and other neuronal second-messenger systems. 
Certain Ras- and Rap-GEFs were found to be activated by direct binding to second 
messengers such as calcium and DAG131. Additionally, PKC inhibition resulted in 
transient Erk1/2 activation after NGF treatment, which is more characteristic of EGF 
stimulation, and resulted in proliferation of PC12 cells132. However, despite growing 
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evidence that other signaling pathways can modulate ERK activity, the exact mechanism 
by which NGF and EGF achieve signaling specificity in PC12 cells remains elusive.  
Rather than honing in on the convergence of signaling pathways at a single point, 
such as ERK, recent studies suggest that multiple pathways could be working in parallel 
and that the balance between these different pathways dictates cell fates. Interestingly, 
Jia-Yun Chen et al. suggest that crosstalk between the PI3K and Ras pathways via the 
activation of the multifunctional protein kinases ERK and Akt, important downstream 
targets of Ras and PI3K signaling respectively, determines the fate of PC12 cells treated 
with NGF. In addition, they identified a feedback link between these two pathways: Rasa 
2 is a late NGF-induced PI3K-related RasGAP that connects PI3K to Ras signaling via 
negative feedback. We were therefore interested in further characterizing the role of 
PI3K/Akt signaling in PC12 cell proliferation and differentiation.In addition, we 
previously found that PKA regulates ERK signaling in PC12 cells in response to both 
EGF and NGF. Various studies have also revealed associations between cAMP-
dependent signaling and the PI3K/PKB/AKT pathway, indicating that PKA operates 
upstream of Akt and can modulate its activity. However, the effects of PKA on Akt 
activity are cell type-specific and complicate our understanding of PKA-Akt cross-
regulation. In COS7 and HEK293 cells, for example, PKA can indirectly inhibit or 
activate Akt by affecting Akt translocation to the plasma membrane and activating or 
inhibiting kinases and phosphatases that control Akt phosphorylation. On the other hand, 
in granulosa cells, PKA enhances Akt activation by promoting phosphorylation of insulin 
receptor substrate-1 (IRS-1) to promote proliferation, differentiation, survival, and 
enhanced mRNA translation. Interestingly, in primary cortical neurons, AKAP150 
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coordinates PKA and Epac-mediated Akt phosphorylation. More importantly, these two 
cAMP-dependent effectors were shown to exert reciprocal effects on neuronal Akt 
signaling. These results provide strong evidence of a link between PKA and Akt 
signaling in cell-fate determination, leading us to also investigate the effect of PKA, an 
upstream regulator of ERK, on Akt activity in PC12 proliferation and differentiation. 
  
RESULTS 
Spatial differences in Akt activity dynamics in PC12 cells 
We first characterize Akt activity in response to EGF and NGF in PC12 cells. 
Given that the plasma membrane is the site of activation for the PI3K/Akt pathway and 
because Akt activity has been shown to differ between plasma membrane raft and non-
raft regions in NIH3T3 cells, we utilized the raft and non-raft targeted FRET-based 
reporter Akt activity reporters, Lyn-AktAR2 and AktAR2-KRAS, respectively, to 
monitor Akt dynamics (Fig. 3.1A,B). AktAR2 contains a molecular switch that consists 
of FHA1 as the PAABD and an Akt substrate domain derived from the sequence 
surrounding Thr-24 of FOXO1 sandwiched between Cer and cpVenE172133. 
Interestingly, upon NGF stimulation, which is known to induce sustained ERK activity 
and drive the neuron-like differentiation of PC12 cells, we observed sustained Akt 
activity in both raft and non-raft regions. Furthermore, when the cells were exposed to 
EGF, which normally induces transient ERK activity and PC12 cell proliferation, we also 
observed transient Akt activity in both of these plasma membrane regions (Fig. 3.1C,D). 
Noticeable differences were observed in Akt activity when PC12 cells responded to EGF 
and NGF.  The first difference is in the amplitude of the FRET response upon growth 
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factor stimulation. Upon EGF stimulation, both raft- and non-raft-localized Akt exhibited 
similar FRET responses (14.8 ± 1.1%, n=14 and 14.04 ± 0.56%, n=28, respectively).  In 
contrast, when treated with NGF, raft-localized AktAR showed a weaker response than 
non-raft-localized AktAR (9.4 ± 0.84%, n=10 and 16.32 ± 0.87%, n=22, respectively) 
(Fig. 3.1D). 
In addition, we compared the kinetic differences between Akt activity in these 
different microdomains induced by the different growth factor treatments. To quantify 
these differences, we employed the Sustained Activity Metric (SAM), defined as follows:  
𝑆𝐴𝑀=𝑅30−𝑅0 
𝑅𝑝−𝑅0 
where R0 and R30 are the response amplitudes at 0 and 30 minutes, respectively, and Rp is 
the maximum response measured between 0 and 30 minutes. Thus, higher SAM values 
generally correspond to more sustained responses, with a SAM value of 1 indicating that 
the response is completely sustained, whereas a SAM value of 0 corresponds to a fully 
adapted, transient response.  In general, EGF induced more transient Akt activity and 
NGF induced more sustained activity. However, raft-localized Akt activity was more 
sustained that non-raft-localized Akt activity in response to EGF treatment (SAM values: 
0.38 ± 0.03 and 0.22 ± 0.03, respectively) (Fig. 3.1E). Under NGF treatment, Akt in the 
raft regions showed more transient activity that non-raft Akt (SAM values: 0.69 ± 0.06 
and 0.92 ± 0.03, respectively) (Fig. 3.1E).  
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Figure 3.1 Growth-factor induced Akt activity in plasma membrane microdomains 
(A) Representative time course plot of PC12 cells expressing AktAR KRAS  and (B) Lyn 
AktAR with EGF (n=28) and NGF (n=22). (C) Bar graph comparing maximum % 
response from AktAR KRAS and Lyn AktAR in response to EGF (n=14) and NGF 
(n=12). (D) Bar graph depicting difference in SAM or % sustained response values of 
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 Other than the plasma membrane, Akt activity has been known exist in other 
subcellular regions. Once activated, Akt can translocate to various subcellular 
compartments, including the endoplasmic reticulum, mitochondria, Golgi and nucleus, 
where it phosphorylates substrates or interacts with other cell components134. Therefore, 
we next examined if the unique temporal dynamics of Akt activity specifically induced 
by each growth factor also extended to other regions of the cell in which Akt activity has 
been detected. We were able to detect Golgi-localized Akt activity. Interestingly, both 
EGF and NGF stimulated transient Akt responses at this region, with maximum 
responses of 4.0 ± 0.34% (n=11) and 6.8 ± 0.6% (n=10), respectively (Fig. 3.2A). The 
addition of either EGF or NGF induced only a minute, transient Akt responses in the 
cytosol, as measured using AktAR NES, with an average maximum FRET ratio changes 
of 2.2 ± 0.23% (n=21) and 1.8 ± 0.15% (n=16) for EGF and NGF, respectively (Fig. 
3.2B). In the nucleus, Akt has been reported to phosphorylate the FOXO family of 
transcription factors, as well as the transcriptional coactivator p300135. In addition, other 
studies have shown that NGF elicits Akt translocation into the nucleus136. Surprisingly, 
we observed no detectable nuclear Akt activity upon EGF or NGF stimulation. In 
addition, other subcellular regions such as the mitochondria and endoplasmic reticulum 
showed no Akt activity upon EGF and NGF treatment (Fig. 3.2C-E).  
 
PKA regulation of subcellular Akt activity 
In order to decipher the mechanism underlying these different spatiotemporal Akt 
activity dynamics in presence of EGF and NGF, we looked towards other signaling 
 




Figure 3.2 Subcellular growth-factor induced Akt activity 
(A) Golgi (B) Cytosol (C) Nuclear (D) Endoplasmic reticulum (E) Mitochondrial Akt 
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molecules that could regulate GF-induced Akt activity. Previously, Herbst et al. showed 
that non-raft localized PKA could be activated by EGF and NGF to regulate cell 
proliferation and differentiation, and other studies have implicated PKA in the regulation 
of Akt activity46. Therefore, we set out to investigate the role of PKA in regulating the 
spatiotemporal dynamics of Akt activity in PC12 cells.  
To test the effect of PKA on Akt activity, we pretreated cells with either a PKA 
inhibitor, H89 (10 µM), or a potent cAMP-elevating cocktail containing both the general 
PDE inhibitor IBMX and the AC activator Forskolin (Fsk) for 10 minutes prior to 
stimulation with either EGF or NGF. Using non-raft-localized AktAR, PKA inhibition 
was found to promote a more sustained EGF-induced Akt response (Fig. 3.3A,B) and a 
more transient NGF-induced response (Fig. 3.3C,D) versus treatment with either GF 
alone. These kinetic changes were also quantified using SAM values and compared to 
those from the GF-alone treatments. H89 pretreatment doubled the SAM value of EGF 
treatment while reducing the SAM value of NGF treatment by more than half. On the 
other hand, upregulating PKA activity led to a more transient EGF-induced Akt response 
(Fig. 3.3A,B) and had no discernible effect on the kinetics of the NGF-induced response 
(Fig. 3.3C,D). These results suggest that PKA does not function as a simple inhibitor or 
stimulator of Akt and that a more complex regulatory interaction is involved in tuning 
subcellular Akt activity patterns. 
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Figure 3.3 PKA modulates growth-factor induced Akt activity at the plasma 
membrane 
(A) Representative curves of AktAR KRAS responses treated with EGF (n=28), 10µM 
H89 and EGF (n=11), and Fsk (50µM)/IBMX (100µM) and EGF (n=11). (B) Bar graphs 
depicting the SAM values for the EGF-related treatments. (C) Representative curves of 
AktAR KRAS responses treated with NGF (n=22), 10µM H89 and NGF (n=12), and Fsk 
(50µM)/IBMX (100µM) and NGF (n=4). (D) Bar graphs depicting the SAM values for 
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Tuning of PKA activity via negative feedback from PI3K/Akt signaling 
Given the complex regulation of Akt by PKA in presence of EGF and NGF, we 
looked into additional mechanisms that could contribute to this complex PKA-Akt 
crosstalk. Cellular signaling cascades are complex systems embedded with non-linearities 
in the form of feedback loops. Therefore, to gain an understanding of plasma membrane 
PKA-Akt crosstalk, we investigated the possible existence of negative feedback from Akt 
to PKA in non-raft regions. To determine if Akt can modulate PKA activity, PC12 cells 
expressing AKAR4-Kras, a non-raft-targeted FRET-based PKA activity reporter, were 
treated with 20 µM LY294002, a PI3K inhibitor. Treatment with LY294002 alone led to 
a robust, 17.6 ± 3.4% (n=18) increase in the AKAR4-KRAS FRET ratio (Fig. 3.4A,B), 
and subsequent treatment with either EGF or NGF failed to elicit any additional PKA 
response. Previously, we showed that both EGF and NGF are capable of inducing a 
noticeable increase in PKA activity at the plasma membrane. However, because 
maximally elevating PKA activity using Fsk and IBMX treatment leads to a maximum 
FRET response of 22.6 ± 1.4% (n=5) in AKAR4-KRAS-expressing PC12 cells, the lack 
of a further response from growth factor treatment after LY294002 pretreatment suggests 
that LY294002-induced PKA activity has already saturated the response range of the 
reporter. Along the same lines, LY294002 treatment following a 10-min treatment with 
either EGF or NGF led to additional increase in PKA activity. As with ERK and Akt, we 
have also shown that PKA exhibits differential activity patterns, being transient in 
response to EGF and sustained in response to NGF. However, regardless of whether cells 
were first treated with EGF or NGF, subsequent stimulation with LY294002 invariably 
led to sustained PKA activity (Fig. 3.4C,D). Taken together, these data suggest that Akt 
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activity has a strong inhibitory effect on PKA at the plasma membrane. Interestingly, in 
the cytoplasm, PKA activity only increased by 1.2 ± 0.7% upon Akt inhibition (Fig. 
3.4E). Subsequent treatment with Fsk and IBMX led to a dramatic increase in PKA 
activity, indicating that that lack of a significant response to LY294002 treatment was not 
due to malfunctioning of the reporter. Given that GF stimulation was also unable to 
induce significant changes in cytosolic Akt activity, the apparent lack of any Akt effect 
on cytosolic PKA could be due to low basal PI3K or Akt activity in this subcellular 
region.  
To further elucidate the mechanism behind the negative regulation of PKA by Akt 
at the plasma membrane, we next investigated the involvement of known negative 
regulators of PKA activity, such as PDEs, that may be regulated by PI3K or Akt. 
Previously, PDE3 was shown to specifically regulate PKA activity at the plasma 
membrane in PC12 cells, thereby preventing active PKA from diffusing into the 
cytoplasm. Therefore, we transfected cells with diffusible ICUE3, a FRET-based cAMP 
reporter, and treated these cells with LY294002. Following LY294002 treatment, we 
detected a larger response from ICUE3 than with either EGF or NGF alone, signifying 
that PI3K may inhibit PKA activity by negatively regulating cAMP levels (Fig. 3.5F).  
 
Determining the role of PKA-Akt crosstalk in PC12 cell differentiation  
To test if the PKA-Akt crosstalk has implications in growth-factor induced neurite 
extension, we treated PC12 cells with various treatments for 3 days and monitored the 
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Figure 3.4 Akt regulation of PKA activity at the plasma membrane 
(A-D) Time course plots of AKAR4-KRAS with indicated treatments. (E) Time course 
plot of AKAR-NES with indicated drug treatments (n=2). (F) Time course plot of ICUE3 
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effects on neurite outgrowth using membrane-targeted YFP to highlight the cell 
membrane and facilitate the quantification of neurite length. Consistent with previous 
reports, we found that NGF induces significant neurite outgrowth (neurites were defined 
as processes with lengths greater than or equal to the length of the cell body), whereas 
EGF treatment does not.  Also in agreement with our previous observations, treatment 
with both EGF and Fsk also induced neurite outgrowth, although the effect on neurite 
outgrowth was not as robust as that of NGF treatment in terms of the number of neurites 
or neurite length46, 137. Interestingly, upon treatment with Fsk, alone, the cells exhibited a 
substrantial amount of neurite extension, more than what was observed in the presence of 
EGF. Since PI3K suppresses PKA activity, we predicted that additional treatment with 
LY294002 would further increase the percentage of differentiating cells, possibly to a 
level that more closely resembles NGF treatment. However, LY294002 treatment in 
presence of either EGF or Fsk failed to further enhance the neurite extension exhibited by 
cells treated with EGF and Fsk (Fig. 3.5). To simplify our understanding of these results, 
we removed EGF from the treatment conditions and observed the functional outcome. 
Upon treatment with Fsk alone, the cells exhibited a substantial amount of neurite 
extension, more than what was observed in the presence of EGF. PC12 cells were then 
treated with a combination of Fsk and LY294002. Even without EGF, however, we again 
observed less neurite extension than expected. This effect may be due to the toxicity of 
LY294002 treatment, as a large portion of the cells died over course of the 2-day 
treatment.  
Other approaches to test the relationship between PKA and Akt in the functional 
assay involve using lower doses of LY294002 to prevent cell death over the course of the  
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Figure 3.5 PC12 Differentiation Assay 
PC12 cells expressing a plasma membrane-targeted YFP were treated for 3 days as 
indicated, and the number of cells expressing neurites (defined as a cellular extension 
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assay or, alternatively, implementing the Akt-specific inhibitor SH-5. Furthermore, to 
address the role of the differential spatiotemporal regulation of GF-induced Akt in PC12 
cell proliferation and differentiation, we plan to incorporate a targetable peptide-based 
Akt inhibitor in the functional assay. This inhibitor will be targeted to different 
subcellular localizations and the importance of their activities will be determined by how 
the functional output differs from the canonical GF treatments. Furthermore, we will 
combine Akt-specific inhibition with growth factor treatment, as well as with PKA 
inhibition and activation, to further characterize the role of PKA-Akt crosstalk in GF-
induced proliferation and differentiation in PC12 cells. 
 
DISCUSSION 
 Traditionally, the temporal pattern of ERK activity has been thought to influence 
whether PC12 cells choose to proliferate or differentiation; transient ERK activity leads 
to proliferation while sustained ERK activity leads to differentiation. Various groups 
have found other signaling molecules that could modulate ERK activity and 
demonstrated ways to perturb the temporal dynamics of ERK, but do not provide a 
complete mechanism to allow full understanding of how cells decide to proliferate or 
differentiate. Therefore, instead of honing in on ways in which ERK can be regulated to 
achieve specific cellular processes, another approach to understanding how cells decide 
to proliferate or differentiate is to investigate other signaling pathways that work in 
parallel with ERK.  
In this study, we investigated Akt signaling in PC12 cells, as this signaling 
pathway has been demonstrated to play a role in cell differentiation in other cell types 
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and to work concomitantly with ERK to regulate PC12 proliferation and differentiation.  
Utilizing FRET-based biosensors to observe spatially compartmentalized Akt 
activity in PC12 cells, we found that upon EGF and NGF stimulation, Akt is 
predominantly active at the plasma membrane, where it is known to be activated by PI3K 
and PDK1. Specifically, EGF induces transient Akt activity, while NGF induces 
sustained Akt activity. Interestingly, their responses mirror the temporal dynamics of 
EGF- and NGF-stimulated ERK activity. We also showed that these two stimuli result in 
completely different spatial patterns of Akt signaling in other subcellular regions. EGF 
stimulation results in consistently transient ERK activity in various sub-cellular 
organelles; however, NGF stimulation results in a range of Akt activity profiles – from 
sustained activity in the plasma membrane to transient activity in the cytosol and Golgi – 
suggesting that these growth factors may engage widely differing signaling mechanisms 
in different subcellular locations. Phosphorylation is the result of a dynamic balance 
between the kinase and cognate phosphatase actions. Spatial gradients in phosphorylation 
have been predicted to occur through differences in the relative concentrations of kinase and 
phosphatase at different locations. This could be attributed to differences in subcellular 
concentrations of phosphatase activity, such as PP1A138. In regions such as the cytosol or 
Golgi, there may be a higher concentration of phosphatases, thus leading to more 
transient NGF-induced Akt activity, compared to NGF-induced Akt activity at the plasma 
membrane. At other subcellular regions, including the nucleus, and at mitochondrial and 
ER membranes, we were unable to detect Akt activity, even though previous studies have 
reported the existence of active nuclear Akt in PC12 cells, along with the implication of 
Akt activity in anti-apoptotic processes. Of note, these specifically targeted Akt activity 
biosensors have been shown to be functional in NIH3T3 cells (Zhou etal, unpublished). 
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These results could indicate the relatively low levels of Akt activity exist in these 
subcellular regions. Future experiments involving subcellular fraction of PC12 cells and 
western blots will help confirm these imaging results.   
Since the cAMP/PKA pathway has been shown to modulate the temporal 
dynamics of GF-induced ERK activity at the non-raft region of the plasma membrane, we 
suspected that the cAMP/PKA pathway could have a similar effect on Akt activity. The 
cAMP/PKA pathway stimulates Akt in some cells and inhibits it in others. Here, we 
demonstrated that either inhibiting or upregulating PKA activity does not simply inhibit 
or activate Akt, but instead alters the temporal dynamics of Akt at the plasma membrane. 
As a results PKA most likely indirectly modulates Akt activity possibly through upstream 
regulators of Akt in the PI3K/Akt pathway, such as PI3K. While PI3K is one of the 
components involved in Akt activation, PI3K has also been shown to be directly 
phosphorylated by PKA at the regulatory subunit on Ser-83, leading to its activation139, 
140. On the other hand, downstream regulators of PKA can modulate Akt activity. For 
example, other studies have shown that Rap1, a downstream target of PKA and Epac, can 
inhibit Akt activity 141. To further decipher this complex interplay between Akt and PKA, 
we also investigated the presence of a feedback mechanism from Akt to PKA. 
Surprisingly, we found that Akt has a strong negative effect on PKA activity at the 
plasma membrane through the downregulation of cAMP levels, possibly through the 
upregulation of PDE3 activity142. However, we have yet to directly test whether PDE3 is 
involved in this regulatory pathway. 
We then attempted to show the importance of Akt-PKA crosstalk in PC12 cell 
proliferation and differentiation. Since upregulating PKA with Fsk causes resting PC12 
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cells to differentiate to a certain extent, we hypothesized that further upregulating PKA 
by blocking Akt at the same time would have a similar or enhanced effect on PC12 
differentiation. However, the toxicity of LY294002 interfered with the differentiation 
assay. Therefore, using lower doses of LY294002 would be beneficial. Moreover, 
LY294002 inhibits the upstream PI3k activity and may have broader effects. Therefore, 
utilizing SH-5, a specific Akt inhibitor could have a less detrimental effect on cells. 
Moreover, the Akt-PKA cross-regulation appears to be predominantly occur at the 
plasma membrane in PC12 cells. As a result, we can specifically inhibit this pool of Akt 
activity determine the functional role of plasma membrane Akt activity in cell 
differentiation. 
  
MATERIALS AND METHODS 
Materials  
EGF, IBMX were purchase from Signm-Aldrich (St. Louis, MO). NGF was purchased 
from Harlan Laboratories. H89 was purchased from Cayman Chemical. Forskolin and 
LY294002 were acquired from LC Labs.                  
 
 Cellular transfection, imaging and analysis. 
PC12 cells were plated on sterilized glass coverslips in 35-mm dishes, and then they were 
grown to 70% confluence in DMEM (10% fetal bovine serum) at 37°C with 5% CO2. 
Cells were transfected with Lipofectamine 2000 (Invitrogen). For imaging, PC12 cells 
were washed with Hanks' balanced salt solution buffer and imaged in. For imaging, cells 
were washed once and then imaged in Hanks' balanced salt solution in the dark at 37°C, 
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on a Zeiss Axiovert 200 M microscope with a cooled charge-coupled-device camera 
(MicroMAX BFT512; Roper Scientific, Trenton, NJ) controlled by METAFLUOR 
software (Molecular Devices, Sunnyvale, CA). Dual emission ratio imaging was 
performed using a 420DF20 excitation filter and a 450DRLP dichroic mirror and 
appropriate emission filters, 475DF40 for cyan fluorescent protein (CFP) and 535DF25 
for yellow fluorescent protein (YFP). Exposure time was 50–500 ms. Images were taken 
every 20–30 s. Imaging data were analyzed with MetaFluor 6.2 software (Molecular 
Devices, Sunnyvale, CA). Cells were treated with drug as indicated, and images were 
analyzed using ImageJ software (NIH). Fluorescence images were background corrected 
by deducting the background (regions with no cells) from the emission intensities of CFP 
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INTRODUCTION 
Protein phosphorylation/dephosphorylation is an important way by which cellular 
proteins are posttranslationally modified to modulate their function. In many cases, 
spatial microcompartmentation of protein kinase and phosphatase activities is required to 
achieve specific and optimized modulation in signaling events and therefore diverse 
physiological responses. Dysregulation of kinase activities and phosphorylation events 
has been implicated in a wide array of pathological diseases10. Therefore, efforts have 
been made to study different kinase activities by engineering biosensors to detect specific 
endogenous kinase activities. FRET-based biosensors have proven to be extremely useful 
tools in detecting and visualizing this spatiotemporal regulation of kinase dynamics. 
Being genetically encoded entails the introduction of a fluorescent reporter into living 
systems at the DNA level, followed by de novo synthesis, and subcellular targeting by the 
endogenous cellular machinery. However, as a result of the exogenous illumination, there 
are limitations to the usage of FRET-based biosensors. First, exogenous illumination can 
lead to high background noise resulting from direct excitation of the acceptor or 
photobleaching. Second, FRET-based reporters are incompatible with non-invasive deep 
tissue imaging of whole organisms and other applications where the cellular substrate or 
drug compounds are autofluorescent. Third, experimental problems also arise when 
additional external illumination is required, such as for optogenetic tools, which prevents 
simultaneous use of fluorescence imaging. Finally, the general light intensity required for 
external illumination sometimes causes phototoxic effects, which alter cellular behavior 
and ultimately leads to cell death. 
 
	   84	  
To overcome some of the limitations, bioluminescence resonance energy transfer-
based biosensors have been developed to monitor cell signaling75, 143, 144. In BRET-based 
readouts, the Cerulean in the FRET-based reporters is replaced with the enhanced variant 
of Renilla luciferase, RLuc8. When situated with proper distance and orientation to a 
suitable acceptor fluorophore, such as a yellow fluorescent protein (YFP). the energy 
produced by the enzymatic oxidation of benzyl-coelenterazine by RLuc8 can be 
transferred to the acceptor fluorophore, such as a yellow fluorescent protein (YFP)145.  As 
a result, no exogenous illumination is required. Moreover, by avoiding the background 
formed by autofluorescence signals, BRET-based biosensors allow for sensitive imaging 
in tissues. With FRET-based biosensors, the blue-shifted illumination required for 
optogenetic tools interferes with the CFP excitation wavelength. In contrast, BRET 
avoids interference from fluorescent compounds. Without the need for exogenous 
illumination, BRET-based reporters can be effectively utilized with optogenetic tools to 
perturb protein activity with high specificity and monitor changes in cell signaling at the 
same time. Novel BRET-based biosensors have been generated to monitor protein-
protein interaction between G-protein coupled receptors (GPCRs) and their binding 
partners, and second messengers such as calcium and cyclic-AMP (cAMP)146-149. 
However, only one BRET-based kinase activity reporter has been developed, a BRET-
based sensor for extracellular signal-regulated kinase (Erk) activity called REV 150. Here 
we present a generalizable design based on the bimolecular version of FRET-based 
kinase activity reporters for the development of sensitive BRET-based sensors to monitor 
the spatiotemporal dynamics of kinase activities, known as Bim-BRET-KARs75, 151. With 
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these new tools, we aim to demonstrate the applicability of these reporters in presence of 
fluorescent compounds and in combination with recently developed optogenetic tools. 
 
RESULTS 
Bim-BRET-KARs for PKA, Akt, JNK, and AMPK 
Using our kinase-dependent bimolecular switch, we redesigned the FRET-based 
Bim-KARs by replacing the CFP with RLuc8, an RLuc variant with enhanced 
luminescent properties, to generate the bimolecular BRET-based kinase activity 
reporters, Bim-BRET-KARs (Fig. 4.1)75, 82, 151, 152. Traditionally our kinase activity 
biosensors are designed as unimolecular constructs. However, by separating the two 
portions of the molecular switch, the basal BRET is decreased, leading to an 
enhancement in the dynamic range. As a result, we first generated a sensor to specifically 
detect protein kinase A (PKA) activity by pairing the RLuc8-FHA1 fusion peptide with a 
YPet peptide containing the PKA-specific substrate from Bim AKAR72 (Fig. 4.2A). Upon 
PKA activation, the PKA-specific substrate is phosphorylated and causes the FHA1 to 
bind to the phosphorylated site. The interaction between the phosphorylated PKA 
substrate and FHA1 brings the two portions of the reporting unit, Rluc8 and YPet in close 
proximity to allow BRET to occur. When expressed in HEK293 cells, the resulting 
biosensor, Bim-BRET-AKAR, produced a yellow-over-RLuc8 emission ratio increase of 
23 ± 6.3% (n = 18) in response to treatment with a cAMP-elevating cocktail of the 
adenylyl cyclase activator forskolin (Fsk) and the general phosphodiesterase inhibitor 3-
isobutyl-1-methylxanthine (IBMX) 46 (Fig. 4.2E,I).  In contrast, the Bim-BRET-AKAR 
T/A mutant biosensor, where the target threonine residue is mutated to alanine, showed a  
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Figure 4.1 Schematic of Bim-BRET-KARs design 
Bim-BRET KARS consists of two portions: kinase-specific substrate attached to YFP 
and phosphoamino binding domain (PAABD) attached to RLuc8. In presence of h-
Coelenterazine and upon kinase activation, RLuc8 can emit luminescence and the 
PAABD can bind the phosphorylated substrate bringing YFP and RLuc8 in close 
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negligible response of 2.4 ± 4.3% (n=15) to the same treatment, indicating that Bim-
BRET-AKAR can be used to detect PKA activity in living cells with BRET-based 
readout (Fig. 4.4 A-D). Here we did not test H89, a PKA inhibitor, because of its 
interference with RLuc8143. 
To test the generalizability of this design, we developed additional Bim-BRET 
reporters for other kinases, Akt, JNK, and AMPK. These kinases have been extensively 
studied due to their roles in tumorigenesis, from cell growth and proliferation to survival  
and motility, responding to cytokines and environmental stress signals, and cell 
metabolism, respectively. Moreover, FRET-based reporters were previously developed to 
detect Akt, JNK, and AMPK activity and have successfully unveiled new molecular 
mechanisms in the regulation of these kinases in response to different stimuli133 153-155. 
With the Bim-BRET Akt reporter, we utilized RLuc8 and cpVenE172, an enhanced 
version of Venus as the BRET reporting unit (Fig. 4.2B). After the addition of 50 ng 
platelet-derived growth factor (PDGF) in NIH3T3 cells, the BRET change of Bim-
BRET-AktAR increased by 15.8 ± 7.3% (n=6). Conversely, treating cells with a PI3K 
inhibitor, LY294002, caused a subsequent inhibition of Akt as demonstrated by the lack 
of BRET change (Fig. 4.2N). Similar to Bim-BRET-AKAR, RLuc8 and YPet were used 
as the BRET pair for Bim-BRET-JNKAR. Upon 5µM Anisomycin treatment, Bim-
BRET-JNKAR generated a 23.5 ± 8% (n=30) over a period of 20 to 50 minutes (Fig. 
4.2C,G,K). The kinetics of Bim-BRET-JNKAR is consistent with that of the FRET-based 
JNKAR reporter in HEK293 cells as well66, 156. Furthermore, pretreatment with JNK  
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Figure 4.2 Characterization of Bim-BRET-KARs 
(A) Schematic of Bim-BRET-AKAR (B) Bim-BRET-AktAR (C) Bim-BRET-JNKAR 
KRAS (D) Bim-BRET-ABKAR. (E) Representative time course plot of Bim-BRET-
AKAR with 50µM Fsk and 100µM IBMX (F) Bim-BRET-AktAR with 100ng PDGF (G) 
Bim-BRET-JNKAR KRASR with 5µM Anisomycin. (H) Bim-BRET-ABKAR with 
20mM 2DG. (I) Representative psuedocolor cell images of cells transfected with Bim-
BRET-AKAR before and after Fsk and IBMX treatment (J) Bim-BRET-AktAR before 
and after 100ng PDGF treatment (K) Bim-BRET-JNKAR with 5µM Anisomycin (L) 
Bim-BRET-ABKAR with 20mM 2DG. (M) Bar graphs summarizing responses of Bim-
BRET-AKAR (Black) and Bim-BRET-AKAR T/A (Red) to Fsk and IBMX, (N) and 
Bim-BRET-AktAR response to PDGF (Black), combination of PDGF and 20µM 
LY294002 (Red), and response of Bim-BRET-AktAR T/A to PDGF after 20 minutes 
(White). (O) Bar graphs summarizing Bim-BRET-JNKAR response to Anisomycin 
(Black), a combination of Anisomycin and JNK inhibitor VII, (Red), and response of 
Bim-BRET-JNKAR T/A to Anisomycin (White) after 40 minutes. (P) Bar graphs 
summarizing Bim-BRET-ABKAR (Black) and Bim-BRET-ABKAR T/A (Red) response 
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Inhibitor VIII suppressed the Anisomycin-induced BRET increase (Fig. 4.2O). We then 
generated and characterized Bim-BRET reporter for detecting AMPK activity in HEK293 
cells, by treating cells expressing Bim-BRET-ABKAR with 2-deoxyglucose (2-DG), a 
non-hydrolyzable glucose analog that inhibits glycolysis and lowers ATP levels, thereby 
activating AMPK157 (Fig. 4.2D,H). Bim-BRET-ABKAR generated a yellow-over-RLuc8 
emission ratio increase of 13.9 ± 5.9 % (n = 29) after a 20-minute treatment with 20 mM  
2-DG (Fig. 4.2H,L,P). In presence of AMPK inhibitor, Compound C, 2DG was unable to 
elicit a change in BRET from Bim-BRET-ABKAR. Importantly, no change in the 
yellow-over-RLuc8 emission ratio was observed in cells expressing Bim-BRET-ABKAR 
T/A (n = 29), confirming that the increase in BRET was caused by reporter 
phosphorylation (Fig. 4.2P).    
 
Detecting subcellular localized kinase activities with Bim-BRET-KARs 
Much of the specificity of cell signaling is attributed to the compartmentalization 
of signaling components to subcellular regions. This formation of microdomains allow 
cells to regulate the activity of signaling molecules to elicit distinct cell responses. 
Therefore, it is important to be able to detect kinase activity in various subcellular 
regions. One important advantage of genetically-encoded KARs is that they can be 
targeted, using subcellular localization signals, to distinct cellular compartments where 
they can detect local kinase activity158.  
 Previously a plasma membrane targeted unimolecular FRET reporter, AKAR4-
Kras, was developed and revealed the dynamic differences in PKA activity amongst  
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plasma membrane microdomains72. As a result, we also generated a Bim BRET version 
that consists of the substrate-YPet unit of Bim-BRET-AKAR targeted to the plasma 
membrane via a CAAX targeting sequence derived from K-Ras, and the RLuc8-FHAI 
portion that is kept in the cytoplasm (Fig. 4.3A).  Specifically, treating cells expressing 
Bim-BRET-AKAR Kras with a combination of Fsk and IBMX caused a 40.6% ± 2.4% (n 
= 27) increase in BRET/RLuc8 ratio, whereas the T/A mutant of the reporter showed no 
BRET change (Fig. 4.3J). DMSO treatment failed to induce PKA activity as well (Fig. 
4.3J). Similarly, upon treatment with Fsk and IBMX, cells expressing a nuclear-localized 
BRET-based PKA reporter, Bim-BRET-AKAR NLS, showed only a small and gradual 
yellow-over-RLuc8 emission ratio increase of 4.0 ± 0.7% after 30 minutes (n = 18), 
which is consistent with the time required for the activated PKA catalytic subunit to 
translocate into the nucleus to phosphorylate its nuclear targets159 (Fig. 4.3E,H,K). Also, 
the reporter did not respond to DMSO (Fig. 4.3K). In addition to subcellular PKA 
activity, we probed the plasma membrane AMPK activity (Fig. 4.3C). 2DG stimulation 
led to a 23.2 ± 1.4% increase (n=23), while pretreatment with Compound C prevented 
induction of AMPK activity by 2DG (n=12) (Fig. 4.3F,I,L). To further prove that Bim-
BRET-ABKAR KRAS was sensing the inhibitory effect of Compound C, cells were 
treated with the vehicle control of Compound C, DMSO. Subsequent treated with 2DG 
led to a large increase in Bim-BRET-ABKAR KRAS response, indicating that the  
reporter accurately detected the disruption of AMPK activity by Compound C. Together 
these data indicate that Bim-BRET-AKAR and -ABKAR can sensitively and accurately 
detect PKA and AMPK activity at subcellular locations, respectively. 
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Figure 4.3 Subcellular Bim-BRET-KARs 
(A) Schematic of Bim-BRET-AKAR KRAS (B) Bim-BRET-PKA NLS (C) Bim-BRET-
ABKAR KRAS. (D) Representative time course plot of Bim-BRET-AKAR KRAS with 
50µM Fsk and 100µM IBMX (E) Bim-BRET-AKAR-NLS with Fsk and IBMX (F) Bim-
BRET-ABKAR KRASR with 20mM 2DG. (G) Representative psuedocolor cell images 
of cells transfected with Bim-BRET-AKAR KRAS before and after Fsk and IBMX 
treatment (H) Bim-BRET-AKAR NLS before and after Fsk and IBMX treatment (I) Bim-
BRET-ABKAR with 2DG. (J) Bar graphs summarizing responses of Bim-BRET-AKAR 
KRAS to Fsk and IBMX (Black), and DMSO (Red), and Bim-BRET-AKAR KRAS T/A 
response to Fsk and IBMX (White) after 20 minutes. (K) Bar graphs summarizing Bim-
BRET-AKAR NLS response to Fsk and IBMX (Black) and DMSO (Red) after 20 
minutes. (L) Bar graphs summarizing response of Bim-BRET-ABKAR KRAS to 2DG 
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A BRET-based sensor design overcomes small molecule fluorescence 
 When fluorescent compounds are utilized with FRET-based reporters the intrinsic 
fluorescence properties increase the background, therefore decreasing the sensitivity of 
the reporters. To demonstrate this, Bim ABKAR, a bimolecular FRET-based AMPK 
reporter was treated with Compound C, which is autofluorescent. Upon the addition of 
Compound C, an immediate increase in background of the CFP channel was observed 
(Fig. 4.4A,B). On the other hand, because Bim-BRET reporters utilize RLuc8 in place of 
CFP and do not require exogenous illumination, the autofluorescence of Compound C 
does not appear in the background reading of RLuc8 channel nor does it interfere with 
the Bim-BRET-ABKAR readout as shown earlier in the chapter (Fig. 4.4C,D).  
 Previously, in a primary drug screen utilizing a FRET-based PKA reporter, 
AKAR3, some fluorescent drugs contributed to abnormal fluorescent changes in the 
FRET readout like Compound C.   Since we have shown that Bim-BRET-KARs can 
overcome this limitation of FRET-based reporters, and detect specific kinase activity, we 
wanted to test the sensitivity of Bim-BRET-KARs in a high-throughput screening (HTS) 
format for future use in drug screens158. Therefore, we plated HEK293T cells transfected 
with Bim-BRET-AKAR into a 96-well plate and monitored BRET changes upon drug 
stimulation. Treatment with Fsk and IBMX generated a 13.1 ± 0.8% increase in PKA 
activity, which is a stark contrast to the control condition with DMSO treatment. In 
addition, the BRET response of Bim-BRET-AKAR T/A remained unchanged after Fsk 
and IBMX stimulation of PKA and with DMSO, the control condition. Similarly, Bim-
BRET- AKAR KRAS was tested in the same format. Normally, signals from subcellular  
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Figure 4.4 Bim-BRET-KARs are ideal for imaging with fluorescent compounds 
(A) Representative time course plot of CFP and YFP intensity of cells transfected with 
Bim ABKAR before and after 20µM Compound C addition (B) Representative CFP and 
YFP channel images of HEK293 cells transfected with Bim ABKAR before and after 
Compound C addition. (C) Representative time course plot of RLuc8 and YFP intensity 
of cells transfected with Bim-BRET-ABKAR before and after 20µM Compound C 
addition. (D) Representative RLuc8 and YFP channel images of cells transfected with 
Bim ABKAR before and after Compound C addition. (E) Time course plot of Bim-
BRET-AKAR and (F) Bim-BRET-AKAR KRAS in HTS format with indicated 
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regions are difficult to detect in high-throughput screening formats because of the low 
dynamic ranges and the very limited area of detection. However, with the bimolecular 
design, the dynamic ranges of targeted reporters are significantly enhanced, therefore 
making imaging in a large cell population possible. Following Fsk and IBMX 
stimulation, Bim-BRET-AKAR KRAS generated 15.9 ± 0.789% (n=27) BRET change 
(Fig 4.4E). Conversely, Bim-BRET-AKARKRAS did not show a response to DMSO 
indicating that response from Fsk and IBMX treatment was due to elevating cAMP levels 
amongst the cells. Also Bim-BRET-PKA KRAS T/A did not respond to either Fsk and 
IBMX or DMSO, further demonstrating that Bim-BRET-AKAR KRAS can specifically 
and robustly detect PKA activity in a HTS setting (Fig 4.4F).  Together these data show 
that Bim-BRET-KARs can be utilized in the presence of fluorescent compounds and has 
potential accurately detecting kinase activity in HTS setting. 
 
Combining Bim-BRET-KARs with Optogenetic Tools 
 Currently, an emerging set of popular tools used to perturb signaling pathways 
with high spatiotemporal resolution to decipher complex biological processes are known 
as optogenetic tools. They allow one to perturb the biological process by acting directly 
on a protein and photoinduce a change of its activity. The protein is required to have a 
light-sensitive module, which may exist within the protein core or be attached, 
genetically or chemically to the protein of interest. So far, these optogenetic tools have 
been used to “uncage” an agonist or antagonist of a particular protein, control 
intracellular concentration of a protein of interest, control protein synthesis, degrade 
proteins, or relocate proteins to subcellular locations. Some of the commonly used 
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optogenetic tools that are naturally light-sensitive include azobenes, phytochromes 
(PHYs), Rhodopsin, and flavorproteins which include light-, oxygen- or voltage-sensing 
(LOV) proteins, plant light-sensitive cryptocrhome (CRY), and blue light-utilizing flavin 
(BLUF) proteins160. Each protein is sensitive to different wavelength of light.  
A recent application of the LOV domain was in the development of a PKA inhibitor 
whose activity was light dependent, called LOV-PKI161. The inhibitor was constructed so 
that the light-sensitive portion, LOV domain, is fused to a portion of a natural occurring 
PKA inhibitory peptide, PKI. In the dark, PKI is hidden within the LOVE domain. But 
upon exposure to blue light, a large conformational changes cause the unfolding of the Jα 
helix in the LOV domain and exposes the PKI so that it can interact with PKA. Because 
luminescence imaging can be performed in the absence of external light, Bim-BRET-
KARs can be partnered with optogenetic tools, such as LOV-PKI 
 To demonstrate this, LOV-PKI tagged with mCherry, a red fluorescent protein 
used as a control, was transfected in HEK293T cells along with Bim-BRET-AKAR 
KRAS. HEK293T cells were first stimulated with Fsk and IBMX and then we applied a 5 
minute exposure to blue light at 435nm to activate LOV-PKI. As expected, a 35.2 + 2.1% 
(n=14) increase was observed from the Fsk and IBMX treatment. However, the 
subsequent decrease from inhibition of PKA was not observed after the 5 minute light 
exposure (Fig. 4.5A). Even an additional 5 minute exposure to blue light was not able to 
induce the PKI effect on Bim-BRET-AKAR KRAS. Furthermore, the relatively long 
exposure to the blue light rapidly caused a decay in the Rluc8 channel, leading to noisy 
signals (Fig. 4.5B). In parallel, cells transfected with just Bim-BRET-AKAR KRAS were 
subjected to the same treatments. Bim-BRET-AKAR KRAS responded as usual to Fsk 
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Figure 4.5 Applying optogenetic tools to Bim-BRET AKAR-KRAS 
(A) Time course plot of Bim-BRET-AKAR KRAS response to Fsk and IBMX, and 
LOV-PKI activation. (B) Time course plot of changes in the Rluc, BRET and RFP 
channel intensities over the course of the experiment. (C) Time course plot of Bim-
BRET-AKAR KRAS response to Fsk and IBMX, and LOV-PKI activation. (D) Time 
course plot of changes in the Rluc, BRET and RFP channel intensities over the course of 
the experiment. (E) Representative curves of cells transfected with Bim-BRET-AKAR 
(black), and a combination of Bim-BRET-AKAR and bPAC (red) stimulated with light 
and subsequently treated with 50µM Forskolin (Fsk). (F) Representative curves of cells 
treated with the same conditions but transfected with Bim-BRET-AKAR KRAS (black), 
and a combination of Bim-BRET-AKAR KRAS and BgAC (red). 
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and IBMX (n=16). Since the sample did not contain LOV-PKI, exposure to blue light 
should not lead to a decrease in PKA activity. However, we did observe a slight decrease 
after a 5 minute exposure to blue light (Fig. 4.5C).  Again, the Rluc8 channel also showed 
a rapid decay after the blue light exposure (Fig. 4.5D). These results show inability of 
LOV-PKI to be activated effectively without damaging the biosensors or even the cells 
for that matter. Additional tests will be required to determine the right amount of 
intensity to activate LOV-PKI in cells since the published experiments from Yi et al. 
were performed in vitro161.  
Another photoactivatable protein that could be used in conjunction with Bim-BRET-
AKAR is the light-gated adenylyl cyclases. Specifically, BLUF (blue light sensor using 
falvin adenine dinucleotide)-activated adenylyl cyclase (bPAC) has been a useful tool in 
elevating cAMP levels in neurons, bacteria, and cilia to monitor changes in organism 
behavior and Ca2+ fluctuations from cyclic nucleotide-gated (CNG) channels 162-165. First 
we tested the effect of stimulated bPAC on Bim-BRET-AKAR KRAS. HEK293T cells.  
The cells were transfected with both constructs and stimulated with one minute exposure 
to blue light. A dramatic transient response was observed, possibly due to the large 
production of cAMP and the rapid degradation by phosphodiesterases, bringing the 
BRET response back to baseline. (Fig. 4.5E) To ensure that Bim-BRET-AKAR was still 
working properly in the presence of bPAC, cells were subsequently stimulated with Fsk. 
However, Fsk was unable to induce a response from Bim-BRET-AKAR. The same 
treatments were applied to cells that were only transfected with Bim-BRET-AKAR. 
Interestingly, exposure to light also caused a large transient PKA activity even though no 
bPAC was present, and the PKA activity was increased by Fsk treatment as normally 
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observed. Similar responses were also observed with the same treatments in cells 
transfected with Bim-BRET AKAR KRAS. These results indicate that the bPAC may not 
be properly activated. Moreover, the light induction could be interfering with the 
luminescence, contributing the large transient response observed in cells transfected with 
and without bPAC. However, the light exposure did not prevent the Bim-BRET-AKAR 
from working properly because upon Fsk stimulation after light exposure, the diffusible 
and plasma-membrane targeted probes in control cells still exhibited a difference in the 
response amplitude, which was observed in previous experiments. As with LOV-PKI, 
additional experiments will be needed to determine the optimum testing conditions 
required for these optogenetic tools to work properly in live-cell imaging setting. 
 
DISCUSSION 
Protein kinases serve as the key regulators of signal transduction cascades by 
phosphorylating protein targets in response to various extracellular and intracellular 
stimuli. In turn, this phosphorylation leads to different effects on protein activity and 
therefore, the propagation of signal transduction to elicit a desired physiological 
response. Dynamic tracking of specific kinase activity in living cells has been made 
possible by a class of genetically encoded reporters based on FRET. It offers sensitive 
ratiometric fluorescence readout, precise molecular targeting, and high spatiotemporal 
resolution compared to other fluorescent kinase sensors. A general modular design for 
such kinase activity reporters based on a phosphorylation-dependent conformational 
switch has been successfully applied to many serine/threonine and tyrosine kinases. Yet, 
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there are limitations to the applicability of FRET-based reporters in presence of 
fluorescent compounds and optogenetic tools. 
As a result bioluminescence-based assays, which do not require exogenous 
illumination and are not susceptible to signal obstruction by autofluorescence, are 
becoming useful tools for these types of experiment conditions and therefore, can achieve 
higher sensitivity than fluorescence-based assays75, 166. Here we presented a generalizable 
design for BRET-based kinase activity, Bim-BRET-KARs by demonstrating the 
functionality and specificity of Bim-BRET-AKAR, Bim-BRET-AktAR, Bim-BRET-
JNKAR, and Bim-BRET-ABKAR in detecting PKA, Akt, JNK, and AMPK activity. 
Additionally, we demonstrated the targetability of these reporters and their ability to 
detect temporally distinct kinase activity in subcellular regions.  
To prove that Bim-BRET-KARs can overcome some of the limitations of FRET-
based reporters, we first tested Bim-BRET-KARs with fluorescent compounds, such as 
Compound C and showed that Bim-BRET-KARs can specifically report on kinase 
activity without interference from fluorescent compounds. Due to the high signal-to-noise 
ratio, the lack of exogenous illumination, and applicability with fluorescence compounds, 
bioluminescence-based reporters are also useful tools to implement in HTS. With Bim-
BRET-AKAR and Bim-BRET-AKAR KRAS, we demonstrated that Bim-BRET-KARs 
can be applied to HTS format. However, since HTS involve averaging the signal amongst 
a whole cell population, the BRET signal is reduced to about half of the reported value in 
single-cell imaging, which is what we also observed in our experiments. Consequently, 
the resolution of the spatiotemporal differences in kinase activity in response to different 
types of compound treatments may be decreased in HTS format. Therefore, future efforts 
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to increase the dynamic range of Bim-BRET-KARs are necessary. Some approaches 
include incorporating brighter luciferases such as a new smaller and brighter luciferase 
called Nanoluc (Promega)167.  
We also attempted to co-image Bim-BRET-KARs with two optogenetic tools, 
LOV-PKI and bPAC. However we were unable to do so due to the sensitivity of 
luminescence to exogenous illumination and the inability to properly activate LOV-PKI 
and bPAC. Additional characterization of LOV-PKI and bPAC in live-cell imaging is 
necessary to determine the proper conditions required to activate LOV-PKI and bPAC 
without generating articfacts in the BRET signals. Moreover, since high intensity light 
was shown to be detrimental to bioluminescence, finding an alternative optogentic tool 
that does not require high light intensity to activate will be beneficial. At the same time, 
incorporating more stable and robust luciferases in Bim-BRET KARS will help 
counteract the damaging effects of exposure to high intensity illumination. 
To further expand the applicability of Bim-BRET-KARs, targeting Bim-BRET 
reporters to additional important organelles such as the mitochondria, Golgi, ER, and 
lysosome can be generated to study their functional role. Furthermore, expanding the 
color variation of BRET-reporters will allow for multiplexed imaging of more that one 
kinase activity at the same time. 
 
MATERIALS AND METHODS 
Construction of Bim BRET KARs 
 RLuc8-FHA1 was PCR amplified and subcloned into pCDNA3 (Invitrogen) containing 
the 3’-NES (LPPLERLTL). YPet and cpVenus-E172 were PCR amplified with forward 
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primers that introduced the PKA-specific substrate (LRRATLVD), JNK-specific 
substrate (DSVKTPEDEGNPLLEQLEKKGGTGGSEL), Akt-specific substrate 
(PRPRSCTWPDPRPEF), or AMPK-specific substrate (MRRVATLVD), or the 
appropriate threonine-to-alanine mutations, and the PCR fragments were subcloned into 
pCDNA3 containing a 3’-NES, a plasma membrane-targeting sequence derived from K-
Ras (KKKKKSKTKCVIM) or NLS sequence (GCIKSKRKDK).  
 
Cell Culture and Transfection   
HEK293, COS-7 and NIH3T3 cells were grown in DMEM cell culture media (Gibco) 
supplemented with 10% FBS and 1% penicillin/streptomycin at 37oC with 5% CO2.  All 
biosensors were transfected into HEK293T, Cos7, and NIH3T3 cells via Lipofectamine 
2000 (Invitrogen) at 60% confluency, according to manufacturer’s protocol. For the Bim 
BRET AktAR reporter, NIH3T3 cells were serum-starved for 24 h. Cells were plated in 
35-mm glass-bottom dishes for single-cell imaging experiments and in 10-cm culture 
dishes for cell-population studies.   
 
BRET Imaging and Analysis 
Cells were imaged on a Zeiss Axiovert 200M microscope with a Evolve EM cooled 
charge-coupled device camera (Photometrics) controlled by METAFLUOR software 
(Universal Imaging, Downingtown, PA).  Cells were maintained in the dark at room 
temperature and washed with Hank’s Balanced Salt Solution (HBSS).  Using a 450DRLP 
dichroic mirror and a 475DF40 emission filter and for luciferase emission and a 535DF25 
for BRET emission, images were acquired immediately after 10uM benzyl-coelenterazine 
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addition. Acquisition time was 90 seconds. Images were acquired every 2-4 minutes. 
Cells were treated with Phorbol-12-myristate-13-acetate (PMA; Sigma), forskolin (Fsk; 
Calbiochem), 3-isobutyl-1-methylxanthine (IBMX), ionomycin (Iono; Sigma), platelet-
derived growth factor (PDGF), anisomycin (Aniso), and 2-Deoxy-D-glucose (2DG) as 
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INTRODUCTION 
Signaling through cAMP influences many biological processes that have been 
presented in earlier chapters, such as cell migration, proliferation, differentiation, and 
metabolism. Aberrations in the cAMP signaling pathway have been shown to have 
implications for clinical conditions such as obesity and type 2 diabetes mellitus, heart 
disease, and neurological disorders. The classic model of cAMP signaling involves 
hormone-mediated activation of G-protein coupled receptors (GPCRs) to initiate a 
cascade of intracellular events involving activation of Gα stimulatory protein and 
transmembrane adenylyl cyclase (tmAC), which generates cAMP.  Many of the cAMP-
mediated signaling events that occur to bring about changes to these cellular processes 
are carried out by cAMP effector proteins, cAMP-dependent protein kinase (PKA), and 
exchange protein directly activated by cAMP (Epac).   
In order to achieve highly specific cellular responses to external stimuli, cells 
organize components of cAMP signaling into discrete microdomains so that different 
pools of cAMP can be generated in response to extracellular signals or intrinsic signals. 
This restriction is partly achieved by phosphodiesterase (PDE), the enzyme responsible 
for the degradation of cAMP. Furthermore, scaffolding proteins such as AKAPs, help 
establish distinct environments within subcellular regions by assembling specific 
signaling complexes. The availability of different pools of cAMP to the local effectors 
within the same compartments should enhance the specificity and efficiency of cAMP 
signaling. 
To analyze the spatiotemporal dynamics of second messenger signaling, a series 
of FRET-based cAMP biosensor, represented by Indicator for cAMP Using Epac (ICUE), 
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was designed by sandwiching full length or truncated Epac proteins, guanine exchange 
factors for the small GTPase Rap1, between two fluorescent proteins168, 169. Upon cAMP 
binding, the sensing domain undergoes a conformational change resulting in a decrease 
in FRET. More recently, we developed ICUE3 with an increased dynamic range by 
changing the FRET acceptor Citrine to a circularly permuted Venus at lysine 194. The 
large dynamic range of ICUE3 (~100% emission ratio change) makes it suitable for 
subcellular targeting for detecting local cAMP changes (e.g., plasma membrane and 
nucleus, primary cilia as addition of subcellular localization tags sometimes leads to 
decreased response amplitudes74, 170, 171. However, since cAMP concentrations vary 
among different cells, tissues and distinct conditions, the current sets of probes have 
limited applicability in situations where the intracellular cAMP concentration is too low. 
For example, ritodrine, a β2-adrenergic receptor (β2AR) partial agonist was unable to 
elicit a response from ICUE3, even though activation of β2AR are known to induce 
increase in cAMP levels168. In addition, often low cAMP levels are picked up by PKA 
activity reporters due to their ability to amplify the cAMP signal through PKA 
phosphorylation activity.  For example, in PC12 cells, both EGF and NGF are able to 
induce PKA activity in the plasma membrane46. Since PKA is activated by cAMP, we 
should be able to utilize the cAMP biosensor to detect changes in cAMP upon growth 
factor treatment. However, both ICUE3 and Epac1-cAMPs, a cAMP reporter containing 
only the cAMP-binding domain of Epac1, were unable to detect changes in cAMP levels 
induced by growth factors172. Therefore, since PKA activity reporters indirectly detect 
cAMP dynamics through PKA activity, generating a more sensitive reporter that directly 
interacts with cAMP is ideal to accurately detect cAMP levels.  
 
	   106	  
RESULTS 
Development and characterization of a more sensitive cAMP biosensor  
Between the two cAMP effector proteins, PKA and Epac share a conserved 
cAMP-binding domain (CNBD). However, the regulatory subunit of PKA has been 
shown to have higher affinity for cAMP than the cAMP-binding domain within Epac1. 
Based on sequence alignment of the conserved cAMP-binding region, Epac1 lacks the 
glutamic acid (Glu) that is necessary for tight binding in PKA. It was proposed that 
Epac1 and PKA both originally possessed the same Glu residue at this conserved site; 
however, to avoid being saturated by cAMP at the resting state of the cell and thus 
incapable of responding to an increase of cellular cAMP, Epac1 evolved away from PKA 
by acquiring an E270Q mutation173. The mutation has resulted in a larger and overall less 
rigid cAMP-binding pocket in Epac1, leading to a lower affinity for cAMP173, 174. As a 
result, we aimed to revert the residue back to glutamine in Epac1, to mimic the cAMP-
binding region within the regulatory subunit of PKA to achieve a more sensitive cAMP-
reporter. 
We incorporated the Q270E mutation into the CNBD of Epac1 within ICUE3 
(Fig. 5.1A). To test whether the mutation enhances the binding of cAMP to ICUE3, we 
purified both ICUE3 and ICUE3 Q270E from HEK293T cells and took 
spectrophotometric measurements to compare the emission spectrum of the two reporters.  
Addition of cAMP decreases yellow emission at 525 nm emission peak, and increases the 
cyan emission at 485nm emission peak, consistent with reduced FRET change of ICUE 
reporters. We calibrated these FRET changes to cAMP concentrations, allowing us to 
measure cAMP responses quantitatively. At 10µM of cAMP, ICUE Q270E elicited  
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Figure 5.1 In vitro characterization of ICUE4 
(A) Schematic of ICUE3 and ICUE4 reporters. (B) SDS gel showing purified ICUE3 and 
ICUE4 at ~152kDa.  (C) Spectra of purified ICUE3 and (D) ICUE4 with and without 
10µM cAMP. (E) ICUE3 and ICUE4 (5µM) incubated with varying concentrations of 
cAMP reveal a dose-response relationship of FRET change to cAMP concentrations 
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~18.5% FRET change, while ICUE3 did not show significant difference in FRET (Fig. 
5.1C,D). This was also evident in the Kd values that were obtained from the 
spectrophotometric experiment, 11.8µM for ICUE Q270E and 39.8µM for ICUE3. 
Moreover, at saturating concentrations of cAMP, ICUE Q270E showed a higher 
maximum FRET change than ICUE3 (Fig. 5.1E). All together these data confirm that the 
Q270E does increase the binding affinity of ICUE to cAMP.  Therefore, we named this 
biosensor ICUE4. 
We then wanted to test the ability of ICUE4 to sense intracellular cAMP levels in 
comparison to ICUE3, to further confirm its enhanced binding. HEK293T cells were 
transiently transfected with either ICUE3 or ICUE4 and then treated with sequential 
submaximal doses of the general β adrenergic receptor agonist isoporterenol (Iso) in 
order to elicit low levels of cAMP production168. Neither ICUE3- nor ICUE4-expressing 
cells responded to treatment with 1 nM Iso; however, both probes maximally responded 
to treatment with a maximal dose of 50 µM Forskolin (Fsk), an adenylyl cyclase agonist, 
indicating the reporters are functional (Fig. 5.2A). At 40nM Iso, both probes produced 
clear, transient responses. In addition, clear differences in the amplitude of the FRET 
change were also apparent between ICUE3 and ICUE4. Whereas ICUE3 showed a 
modest 48.3 ± 5.2% (n=4) FRET ratio change, ICUE4 showed a 56.6 ± 10.8% (n=5) 
response (Fig. 5.1B). Increasing Iso concentrations subsequently induced larger responses 
from ICUE4 than from ICUE3 (Fig. 5.1C-F), suggesting that, in addition to enhancing 
the cAMP binding affinity of ICUE, the Q270E mutation also improves the dynamic 
range of the reporter. However,  
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Figure 5.2 Characterization of ICUE4 with Isoproterenol 
(A) Comparison of ICUE3 and ICUE4 FRET responses to 1nM (black n=6, red n=4), (B) 
40nM (black n=4, red n=5) (C) 50nM (black n=4, red n=7), (D) 80nM (black n=2, red 
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we did not detect a clear relationship between the magnitude of the FRET change and the 
Iso concentration used, either with ICUE4 or with ICUE3. This discrepancy may be due 
to cell-to-cell variations in receptor expression levels. 
Therefore, we next utilized the direct adenylyl cyclase activator forskolin, which 
is not influenced by receptor expression, in order to reduce cell-to-cell variability in 
cAMP production. In the presence of a low dose (5 µM) of Fsk, cells expressing ICUE3 
produced a 3.7 ± 0.8% (n=3) FRET response, while ICUE4-expressing cells displayed an 
11 ± 2.09% (n=3) FRET change (Fig. 5.2A, B). At 10 µM Fsk, ICUE3 started to show a 
more dramatic difference, with only a 20.97 ± 2.9% (n=5) FRET change compared with 
45.2 ± 2.01% (n=5) for ICUE4. At 30 µM and 40 µM Fsk, ICUE4 continued to show a 
larger response to cAMP than ICUE3. However, whereas the FRET response from 
ICUE3 continued to increase from 40.2 ± 5.5 % (n=7) to 61.6 ± 6.5% (n=8) for 30 µM 
and 40 µM Fsk, respectively, ICUE4 displayed similar FRET responses of 75.8 ± 8.0% 
(n=8) and 77.9 ± 4.0% (n=10) to both treatments (Fig. 5.2A, B). The lack of an additional 
increase from ICUE4 even though the Fsk concentration was increasing, may indicate 
that the response from ICUE4 has already saturated at 30 µM Fsk due to the potentially 
higher binding affinity enabled by the Q270E mutation. Based on these results, ICUE4 
detects intracellular cAMP more sensitively than ICUE3. Moreover, the Q270E mutation 
appears to have increased the dynamic range.  
 
Employing ICUE4 in PC12 cells 
The sensitivity of ICUE4 towards low levels of cAMP was tested in a setting 
where the cAMP levels are nearly undetectable using ICUE3. Previously, it was shown  
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 Figure 5.3 ICUE3 vs. ICUE4 responses to increasing Forskolin concentrations 
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that in PC12 cells, both EGF and NGF were able to induce PKA activity. Since PKA is 
activated by cAMP, we hypothesized the growth factors could be upregulating PKA 
activity through cAMP. However, ICUE3 was unable to detect the change in cAMP level. 
This type of discrepancy between the PKA and cAMP-binding reporters is often due to 
the ability of the PKA reporter (AKAR) to amplify the cAMP signal through multiple 
phosphorylation events72. We therefore transfected PC12 cells with either ICUE3 or 
ICUE4 and compared their FRET responses after GF stimulation. After 30 minutes of 
100 ng/mL EGF stimulation, ICUE3 showed only a 0.8 ± 1.8% (n=4) FRET response, 
whereas an identical treatment elicited a 9.4 ± 1.3% FRET (n=11) change from ICUE4 
(Fig. 5.4A, B). A similar trend was observed when the PC12 cells were treated with 200 
ng/mL NGF, with ICUE3 and ICUE4 displaying average FRET ratio changes of 2.1 ± 
1.4% (n=4) and 7.6 ± 2.0% (n=7), respectively (Fig. 5.4C, D). 
Additionally, we previously applied ICUE3 to detect LY294002-induced cAMP 
levels (see Chapter 3). The overall kinetics of the ICUE3 responses were slow, possibly 
indicating that cAMP levels were again low in PC12 cells. However, unlike the response 
observed from ICUE3 (4.1 ± 1.1%, n=4), ICUE4 showed a more rapid and robust 
response to LY294002 treatment (12.0 ± 1.7%, n=5), further demonstrating that ICUE4 is 
a more sensitive probe that can be utilized to detect small, physiologically relevant 
changes in cAMP levels (Fig. 5.4E). 
 
DISCUSSION 
cAMP is an important second messenger that has a large influence on cell 
signaling and thus biological processes in response to various types of external stimuli.  
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Figure 5.4 ICUE4 detects growth-factor induced cAMP in PC12 cells 
(A) Quantification of ICUE3 and ICUE4 responses to 100ng/mL EGF and (B) 200ng/mL 
NGF. (B-C) Representative time course plot of ICUE3 and ICUE4 with either EGF or 
NGF treatments (E) Time course plot of ICUE3 and ICUE4 response to 20µM LY294002 
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Cells are known to compartmentalized cAMP singling to where it is needed most to 
induce specific cellular responses. As a result, the concentration of cAMP is uniform 
throughout the cell. The differences in cAMP levels within various microdomains can be 
visualized using FRET-based reporters such as ICUE3. However, it has been shown to be 
insensitive to low cAMP concentrations. Therefore through structural studies, Dao et a.l, 
identified a key residue in Epac, that if mutated to mimic the tight binding of PKA 
tocAMP, could enhance the binding of Epac to cAMP. By incorporating this Q270E 
mutation in ICUE3, which utilizes Epac as its molecular switch, we demonstrated both in 
vitro and in vivo that ICUE4 has increased affinity for cAMP and significantly larger 
dynamic range.  Furthermore, we employed ICUE4 in a setting where changes in cAMP 
levels are detectable by AKAR, but not ICUE3 due to the extremely low levels of cAMP 
and the ability of AKAR to amplify the cAMP signals. ICUE4 successfully detected 
growth-factor and LY294002 induced increase in cAMP levels in PC12 cells. As a result, 
ICUE4 will be useful in uncovering dynamic changes in cAMP levels that had once 
escaped our detection. 
 
MATERIALS AND METHODS  
In vitro fluorescence assays 
After 48 hour transfection, HEK293T cells were spun and lysed in a buffer pH 7.4 
containing 50mM Tris-HCl, 100mM NaCl, 1mM EDTA, 1mM PMSF, protease inhibitor 
cocktail (Roche), and 0.2% Triton X-100 in a Dounce homogenizer. Lysed cells were 
spun and 50 µL of Ni-NTA beads (Qiagen) was added to the supernatant. The beads were 
spun, washed once in buffer containing 10 mM imidazole, and eluted in buffer containing 
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100 mM imidazole. Purified protein was detected by Coomasie stain (Pierce 
Biotechnology) and western analysis using anti-GFP antibody (eBioscience). 
Fluorescence spectra of ICUE3 and ICUE4 were measured with excitation at 435 nm 
before and after addition of cAMP. Spectrum reading was taking between 450 to 600nm. 
Integration time was set to 0.5sec. Slit size for excitation wavelength was set to 1 while 
emission slit size was set to 5. FLuoromax-3 fluorimeter from Horiba scientific was used 
to take the spectrum reading. Each sample was read three times, and each reading was 
background subtracted and normalized to the CFP peak at 475 nm. 
 
Cell Culture and Imaging 
HEK293T cells were grown in DMEM cell culture media (Gibco) supplemented with 
10% FBS and 1% penicillin/streptomycin at 37oC with 5% CO2.  HEK293T cells were 
transfected with Lipofectamine 2000 (Invitrogen). For imaging, PC12 cells were washed 
with Hanks' balanced salt solution buffer and imaged in. For imaging, cells were washed 
once and then imaged in Hanks' balanced salt solution in the dark at 37°C, on a Zeiss 
Axiovert 200 M microscope with a cooled charge-coupled-device camera (MicroMAX 
BFT512; Roper Scientific, Trenton, NJ) controlled by METAFLUOR software 
(Molecular Devices, Sunnyvale, CA). Dual emission ratio imaging was performed using 
a 420DF20 excitation filter and a 450DRLP dichroic mirror and appropriate emission 
filters, 475DF40 for cyan fluorescent protein (CFP) and 535DF25 for yellow fluorescent 
protein (YFP). Exposure time was 50–500 ms. Images were taken every 20–30 s. 
Imaging data were analyzed with MetaFluor 6.2 software (Molecular Devices, 
Sunnyvale, CA). Cells were treated with drug as indicated, and images were analyzed 
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using ImageJ software (NIH). Fluorescence images were background corrected by 
deducting the background (regions with no cells) from the emission intensities of CFP or 
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The ability of cells to recognize, adapt and respond to wide array of external 
conditions is critical for regulating various cellular processes in order to survive. Cells 
respond to these changes by modulating the inner workings of intracellular signaling 
pathways that ultimately alter cellular processes. In order for cells to achieve specific 
cellular responses, cells exploit the precise spatial localization and temporal dynamics of 
different signaling molecules. Investigation of these intricate signaling networks allows 
us to understand how these processes manifest and occasionally malfunction, all in the 
hopes of preventing and/or treating conditions that arise from dysregulation of signaling 
pathways. To gain a precise understanding of the mechanisms involved in these tight 
regulation of signal transduction, one needs to study these networks in their native 
environment. Utilizing FRET-based biosensors in conjunction with biochemical and 
molecular biology techniques, allows us to investigate intracellular signaling events in 
their native context. Specifically, with the help of FRET-based reporters, we were able to 
investigate the molecular determinants of cAMP/PKA signaling specificity in distinct 
cell-based systems.  
 With the aid of plasma membrane targeted KARs in conjunction with 
microfabrication devices, and AFM, we discovered the differential PKA activity levels in 
CHO-α4WT cells undergoing different degrees of physical confinement. In response to 
physical confinement, cells suppress PKA activity to activate components of cell 
migration that allow for efficient movement through confined spaces. PKA is negatively 
regulated by elevated intracellular calcium in confined cells via phosphodiesterase 1 
(PDE1)-dependent mechanism and tunes myosin II/Rac1 activities to promote cell 
motility.  The myosin II/Rac 1 pathway in turn suppresses PKA.  This circuit activity is 
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amplified by double negative feedback, leading to maximized cell responses to 
confinement. We further demonstrate the existence of two confinement-sensing 
mechanisms that are mediated by the Ca2+/PDE1/PKA and myosin II/Rac1 signaling 
modules, respectively. This study provides a novel paradigm by which confinement-
induced signaling enables cells to adapt to different physical microenvironments.  
In a second study, we used FRET-based biosensors for PKA and Akt activities 
targeted to distinct subcellular locations to elucidate the molecular mechanisms 
underlying GF signaling specificity in PC12 cells.  In doing so, we first characterized the 
precise spatiotemporal patterns of EGF- and NGF-induced Akt activities throughout 
subcellular regions of PC12 cells. We have also revealed the tight spatiotemporal 
regulation of PKA activity on GF-stimulated Akt activity at the plasma membrane as well 
as the negative feedback from Akt to PKA. As a novel level of regulation underlying the 
GF signaling specificity in this classical system, we again present an example of signal 
transduction cross-talk where the precise spatiotemporal regulation of one signaling 
pathway controls the spatiotemporal regulation of another. Interestingly, we also 
observed that simply elevating cAMP levels through AC activation can induce neurite 
outgrowth. This is interesting because this effect bypasses the need for growth-factor 
receptor activation, which challenges the classically accepted hypothesis. Since Akt also 
has effect on PKA activity, the PKA-Akt crosstalk may play an important role in 
regulating PC12 differentiation. Collectively these findings have elucidated differential 
subcellular Akt activity specific to PC12 cells and new insights into additional 
mechanisms that are required for GF signaling specificity in PC12 cells. 
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Finally, while FRET-based biosensors have proven powerful tools to study the 
spatiotemporal regulation of signal transduction in the native cellular context, further 
improvement of these sensors in terms of sensitivity and versatility of detection is needed 
to facilitate the use of these tools in applications such as in vivo imaging, high throughput 
compound screening, and possibly co-imaging with optogentic tools. Thus, for the 
specific case of kinase activity detection, we have designed a series of BRET-based 
biosensors, which is generalizable both in terms of kinase specificity and readout, and 
can thus be used to sensitively track dynamic kinase activities in a variety of systems and 
formats. With the design of these sensors we have enhanced the molecular toolkit to 
detect various kinase activities, broadening the application of these tools for the use of 
tracking signal transduction in the native cellular context.   
  Throughout this work we have shown that proper signal transduction is necessary 
for the conversion of a specific environmental stimulant into a distinct cell fate, and it is 
thus critical that the cell tightly regulates signal transduction in both space and time.  If 
this proper regulation is not maintained, the result can be detrimental to the cell, tissue, 
and/or organism, and this is the case in many diseased states.  Therefore, understanding 
the molecular regulatory mechanisms underlying signal transduction in a given system, 
and identifying the molecular discrepancies in these signaling mechanisms between the 
normal and diseased states will facilitate the identification and characterization of 
molecular targets for therapeutic intervention.  As cAMP is a ubiquitous second 
messenger and implicated in the regulation of a variety of physiological processes, the 
findings presented in this work are likely influence and will have implication in the 
further characterization of cAMP-mediated signaling specificity in a variety of systems. 
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o Determining and comparing mechanisms underlying cell migration in 
confined and unconfined spaces 
§ Studying how PKA differentially regulates cell migration in 
confined and unconfined spaces 
• Screening compound library for potential inhibitors of kinases 
o Developed FRET/BRET-based assay for single-cell imaging and high-
throughput screen 
• Acquired proficiencies in live cell fluorescence imaging, bioluminescence 
detection in single cell and 96 well formats, high-throughput compound 
screening, immuno-based assays, protein purification, tissue culture, mammalian 
cell fractionation, and molecular modeling 
• Developed the creative ability to analyze many biological problems and data-sets 
and to devise solutions to solve various scientific challenges in a highly self-
motivated manner 
• Refined my verbal and written scientific communication skills to communicate in 
both a technical and simple manner 
• Mentored and trained 2 students joining the lab 
 
Graduate rotation student research 
Johns Hopkins University School of Medicine, Baltimore, MD, USA (Fall 2010) 
Pharmacology and Molecular Sciences, Ph.D. Candidate  
Advisor: Philip Cole 
 
University of California, Irvine (Fall 2007-Spring 2010) 
Molecular Biology and Biochemistry Department, Research Assistant  
Advisor: Sheryl Tsai, Ph.D. 
• Conducted structural characterization of bacterial acyl-CoA carboxylase 
(ACCase) as a potential therapeutic target for Tuberculosis 
o Performed protein purifications/screenings/and crystallization  
o Conducted protein kinetic assays 
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Based Biosensors in Live Cell Compound Screens. In Fluorescent 
Protein-Based Biosensors (pp. 217-225). Humana Press. 
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agonist (−)-alotaketal A. Organic & biomolecular chemistry, 11(19), 
3212-3222. 
 
• Huang, J., Yang, J. R., Zhang, J., & Yang, J. (2012). Total synthesis of 
the potent cAMP signaling agonist (−)-alotaketal A. Journal of the 




• Undergraduate Research Opportunities Program (UROP) Symposium  
o Spring 2007 Discovering and Developing: Crystallization of Hec1 and the 
Promise for Future Drug Design 
o Spring 2008 Discovering and Developing: Detecting the Activity of 
AccB1420V by Kinetic Analysis 
o Fall 2008 Discovering and Developing: Crystallizing AccD4  
 
• Chemistry Summer Undergraduate Research Fellowship (Chem-SURF) 
Symposium 
o Summer 2009 Discovering and Developing New Tuberculosis 





• Allergan Summer Research Fellowship (Summer 2009) 
• Chemistry Summer Undergraduate Research Fellowship (Chem-SURF) (Summer 
2009) 




Jin Zhang, Professor of Pharmacology 
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Johns Hopkins University School of Medicine 
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